Podcasts about Munich

Ed Sheeran BioSnap a weekly updated Biography.Ed Sheeran has been in the spotlight with several significant developments in recent days. Most notably, the ginger-haired troubadour is currently on his Loop Tour, bringing intimate performances to venues across Europe. According to concert listing information, Ed performed at Olympiastadion München in Munich on December third, twenty twenty-five, as part of this newly announced tour supporting his latest album Play.Coming up imminently, Ed is set to perform at Dublin's iconic Three Arena on December ninth, twenty twenty-five, marking one of only a few Irish dates on the tour. This show represents a notable shift in Ed's career strategy, moving away from massive stadium spectacles to more emotionally resonant performances in mid-sized venues. The Loop Tour setlist will feature new material from Play, including tracks like Zero Gravity and Sunburnt Letters, alongside his greatest hits such as Perfect, Thinking Out Loud, Bad Habits, and Shape of You.On the business front, Ed's record label Warner Music Group has made a significant corporate move. Warner announced a landmark partnership with AI music firm Suno, settling previous litigation between the companies. This collaboration aims to create next-generation licensed AI music while giving artists opt-in control over how their names, voices, and compositions are used in AI-generated songs. According to Warner's CEO Robert Kyncl, this deal benefits the creative community by ensuring AI becomes pro-artist through licensed models and new revenue opportunities. Suno plans to launch more advanced licensed models in twenty twenty-six, with new download restrictions on the platform's free tier.Additionally, Ed recently performed a rendition of Merry Christmas live in Paris during twenty twenty-five, showcasing his acoustic capabilities in a powerful concert performance that highlighted his storytelling strength.On a more personal level, reports indicate Ed has opened up about challenges in his seven-year marriage, providing rare insight into his private life in recent interviews. This candid discussion marks an unusual departure from his typically guarded approach to personal matters.Collectively, these developments show Ed Sheeran actively managing both his touring schedule and business ventures while remaining committed to his artistic evolution through the Loop Tour and intimate venue strategy.Get the best deals https://amzn.to/3ODvOtaThis content was created in partnership and with the help of Artificial Intelligence AI

In this episode of WTiN's Textile Innovation Podcast we speak with WTiN's head of content Madelaine Thomas and innovation & consultancy lead Jessica Robe.We have had a busy few months at WTiN, not only have we hosted our first ever Circularity Week, which took place between 17 – 20 November, but we have also attended textile tradeshows including ITMA ASIA + CITME Singapore 2025 and Performance Days. Our head of content Madeline Thomas attended ITMA Asia + CITME at Singapore Expo, Singapore, while Jessica Robe, innovation & consultancy lead was present at Performance Days 2025 at Trade Fair Centre Messe Munchen, Munich, Germany. During this podcast we speak with both Thomas and Robe about the conversations they were a part of and what they saw at both events. ITMA Asia + CITME is Asia's leading textile and garment technology exhibition, and we discuss how the region is growing and which countries we can expect to see more fromThe bi-annual Performance Days fair meanwhile focuses on functional textiles. During the discussion Robe tells of new exhibition areas at the event, such as wool and footwear. We also touch upon themes and areas of interest such as textile-to-textile recycling and digital textile printing throughout the podcast. If you want to learn more about each tradeshow you can read WTiN's ITMA Asia + CITME 2025 review here and Performance Days 2025 review here. 

Recorded live at MAPIC 2025 in Cannes, this episode features a rare deep-dive with Ian Sandford, President of Eurofund Group, one of Europe's most influential retail property operators. With more than €2B in assets across Spain, Portugal, Italy, Germany and the UK, Eurofund sits at the centre of the sector's biggest shifts.--------*Welcome to the official  channel of THE RETAIL PODCAST, the leading community for global retail leaders, innovators, and changemakers.*If you are struggling to stay relevant in a rapidly evolving industry, looking for insights from major conferences like NRF, Shoptalk, and EuroCIS, or aiming to connect your digital funnels to physical events with measurable ROI, this channel is designed for you.➡️ Hosted by Alex Rezvan and joined by some of the most respected voices in the sector, The Retail Podcast brings sharp, actionable insights from industry veterans with backgrounds at Microsoft and Verizon, where projects worth over $1.5 billion were directed. Our mission is to help retailers and businesses that sell to retailers anticipate change, embrace technology, and unlock new growth opportunities.Here you will discover exclusive interviews with executives and innovators, coverage of global retail conferences, analysis of technology and AI trends, in-depth explorations of fashion, grocery, luxury, and eCommerce, and thought leadership that keeps your strategy relevant all year long. As part of the RetailNews.AI ecosystem, this channel does more than report the news—it shapes the conversation on the future of retail.*Subscribe now and activate notifications so you never miss the strategies, stories, and signals defining tomorrow's retail.*--------

Seasoned shlucha Danielle Chaimovitz has nurtured communities in Estonia, Poland and Germany. A daughter of olim, she was always drawn to communal roles in Jewish life, and she and her husband have made it their specialty to help small communities thrive. Danielle and I discuss the role of a shlucha - what does success look like? How much should your children be part of your work? Should you ever be advising your community to leave? I'm surprised and touched to learn the incredible ways the Munich community supported them through the October 7th war, and fascinated by the subtle differences she's discovered between communities, and how that's affected her leadership style. Our new beginner's Gemara course starts this Thursday, 4th December - a deep yet accessible course to help students feel confident navigating the Talmud. Find out more and book at In Depth Talmud: Studies in Sanhedrin.  This podcast is powered by LSJS. Visit lsjs.ac.uk/learning to learn about our Jewish learning journeys & find something that suits you. NEW! Talk to us at womensgallery@lsjs.ac.uk and tell us who you'd like to hear interviewed.

Leonard Sommer argues schools are stuck in an industrial model and kill creativity. He shares proven examples and methods to redesign student experience. Learn why culture, not curriculum, matters and how businesses can partner with schools to prepare future workers and protect human creativity in the AI era. About Leonard Sommer Since 2014, Leonard Sommer has been actively promoting creativity in education through the Classroom Thinktank e.V., a non-profit initiative he founded. He is also involved on a voluntary basis with several educational organizations, including Education Y (Board Member), Wir für Schule (Advisory Board), and DigitalSchoolStory (Brand Ambassador). Additionally, he is the initiator and curator of FUTUROMUNDO EDU, the International Future Festival of Learning. Leo is the author of the professional book "Wenn Schule auf Ideen bringt – 100 Kreative denken Lernen neu" (Vahlen Verlag, Munich). He is regularly invited as a keynote speaker and workshop facilitator on the topics of creativity in education and future-oriented learning. He has spoken or led workshops at various training programs, events, and global institutions. Resources FUTUROMUNDO : https://www.linkedin.com/in/leonardsommer/ Please, hit the follow button and leave your feedback: Apple Podcast: https://www.cxgoalkeeper.com/apple Spotify: https://www.cxgoalkeeper.com/spotify Follow Gregorio Uglioni on Linkedin: https://www.linkedin.com/in/gregorio-uglioni/ Gregorio Uglioni is a seasoned transformation leader with over 15 years of experience shaping business and digital change, consistently delivering service excellence and measurable impact. As an Associate Partner at Forward, he is recognized for his strategic vision, operational expertise, and ability to drive sustainable growth. A respected keynote speaker and host of the well-known global podcast Business Transformation Pitch with the CX Goalkeeper, Gregorio energizes and inspires organizations worldwide with his customer-centric approach to innovation.

You know Dasher, and Dancer, and Prancer, and Vixen.  Santa, and Frosty, and Rudolph, and Dickens.  But do you know? The Alluring Dark Spirits of old?   In this episode, you can meet three of the Dark Spirits of the Christmas with my guest Tania Yager. Tania is the author of the book The Allure of the Dark Spirits (which will be available Dec. 5, 2025 on Lulu). We talk about the process of getting the book written and about the three topics of the book: Krampus, La Befana, and the Mari Lwyd. The book "is a whimsical, bombastic, and deeply heartfelt journey into the shadowy magic of winter folklore. Part memoir, part shamanic exploration, and part folklore celebration, Yager invites readers to walk beside her as she meets the Alpine Krampus in the snowy streets of Munich, seeks out the Italian witch La Befana, and revisits her own bittersweet ties to Wales through the ghostly Mari Lwyd." We had a great discussion (one of the longer I've done) talking about her journey and about the spirits.  The book will be available for order on Dec. 5, 2025 (Krampusnacht) in time for the holiday season. A gift for yourself and that special friend in your life who also enjoys the spirits of winter.  This is a longer episode, so here is a bit of a show flow: 0:00:00 Introduction and background of Tania and developing the book 0:35:28 Frau Perchta/Frau Holle 0:47:33 Krampus 1:02:00 La Befana 1:11:20 Mari Lwyd - Mari Beast 1:37:56 New Projects, closing   Yager is a multifaceted visual/ performance artist, writer, holistic educator, and shamanic practitioner. She has dedicated her life to the art of storytelling in all forms and strives to put the education at the forefront of her work. She is the creative director of Twisted Heart Puppetworks and founder of The Wild Hunt of Vista Krampus Run and The Dark X-mas Market of Vista. Through her works, she aims to inspire others to explore folklore, fantasy, myth and magic.  Order the book beginning Dec. 5, 2025 on Lulu. Find the link at The Wild Hunt of Vista.com Check out the Dark X-mas Market in Vista California on Dec .13 2025.  Follow Tania on IG & FB: @twistedheartpuppetworks  and IG: @wildhuntersvista The Dark Market on IG & FB: @thedarkxmasmarket    # # # Create your podcast today! #madeonzencastr Subscribe to Substack: https://giftsofthewyrd.substack.com/ Instagram: @wyrdgifts1 Facebook: @GiftsoftheWyrd Email: giftsofthwyrd@gmail.com Order The Christmas Oracle Deck created by me and artist Vinnora at https://feniksshop.etsy.com follow FB/IG: @thechristmasoracle  This product was sent to me by the publisher. I have not been compensated for this interview or review, and my opinions are my own.  Music. Royalty free music from https://www.fesliyanstudios.com  Intro: Land of 8 Bits. Outro: The Night Before Christmas.   Gifts of the Wyrd Logo Created by Xan Folmer.  Logo based on the Vanic boar created by Vanatru Priestess Ember of the Vanic Conspiracy. Studio recordings using Zencastr and Audacity.  

Send us a textIn this episode of the FuturePrint Podcast, we speak with Martin Burns, Business Development Manager for Nazdar's OEM Ink division, about how the company is driving innovation across the fast-evolving world of industrial inkjet.While many in the industry know Nazdar for its global ink portfolio, the OEM division operates differently—functioning as a specialist R&D partner for equipment manufacturers, integrators and emerging industrial innovators. Martin explains how his team acts as an extension of partners' technical groups, providing chemistry expertise, printhead insight and application knowledge that most OEMs cannot resource internally. This collaborative model accelerates development and supports more reliable and more capable inkjet systems.A major theme of the conversation is Nazdar's ultra-high-viscosity inkjet technology, capable of jetting at up to 100 cP. This opens a much wider formulation space, enabling new levels of stability, opacity, adhesion and performance. Martin outlines its impact across several sectors: textiles, where higher-density whites improve hand-feel and wash resistance; corrugated packaging, where better optical density can be achieved even on uncoated substrates; and coding and marking, where high-speed barcodes and QR codes benefit from sharper definition.Water-based development remains central to Nazdar's strategy, particularly for markets where regulatory and environmental pressures demand safer, lower-impact inks. Martin describes how Nazdar is helping OEMs overcome challenges around drying, energy consumption and substrate performance.Finally, Martin previews Nazdar's participation at FuturePrint Industrial Print in Munich, where senior members of the OEM team—including R&D chemists—will be on site for in-depth technical discussions. Rather than a traditional sales booth, the aim is to enable meaningful collaboration and accelerate the next wave of inkjet innovation.Listen on:Apple PodcastGoogle PodcastSpotifyWhat is FuturePrint? FuturePrint is a digital and in person platform and community dedicated to future print technology. Over 20,000 people per month read our articles, listen to our podcasts, view our TV features, click on our e-newsletters and attend our in-person and virtual events. We hope to see you at one of our future in-person events:FuturePrint TECH: Industrial Print: 21-22 January '26, Munich, Germany

Send us a textIn this episode, Marcus sits down with Bas Buser, one of the most respected voices in plasma surface treatment and global printing applications, to explore why plasma has become a critical enabler for industrial inkjet.Bas explains the remarkable story behind Plasmatreat, founded over 30 years ago when Christian Buske pioneered Openair-Plasma, allowing plasma activation outside of vacuum chambers and directly inline with production systems. Today Plasmatreat operates worldwide, supporting automotive, electronics, medical, packaging, and now fast-growing areas of industrial print.Listeners will discover why plasma treatment is now essential for UV and inkjet adhesion: increasing surface energy, cleaning contamination, introducing chemical functionality, and enabling inks to bond to plastics, metals, glass, and recycled materials. Bas shares real-world examples from automotive (50–70 plasma applications per vehicle), packaging (printing QR codes on varnished surfaces), electronics (conductive inks), and medical devices.The conversation also uncovers plasma's role in sustainability — from eliminating solvent-based primers and reducing oven energy use to increasing material choices, lowering ink consumption and minimising rejects.Bas emphasises the importance of collaboration across printheads, inks, integrators, OEMs and converters. He previews Plasmatreat's involvement at FuturePrint Industrial Print Munich, where the team will demo live plasma treatments and invite visitors to test their own substrates.Whether you work in inkjet development, printing, coating, converting or advanced manufacturing, this episode offers a rare level of clarity on one of the most important enabling technologies in modern industrial print.Listen on:Apple PodcastGoogle PodcastSpotifyWhat is FuturePrint? FuturePrint is a digital and in person platform and community dedicated to future print technology. Over 20,000 people per month read our articles, listen to our podcasts, view our TV features, click on our e-newsletters and attend our in-person and virtual events. We hope to see you at one of our future in-person events:FuturePrint TECH: Industrial Print: 21-22 January '26, Munich, Germany

"The Light of the Lord" - Isaiah 2:1-5 Behold Your God Taylor Whitson, CityChurch Bristol, November 30, 2025.   Artwork Credits: Peter Paul Rubens, The Defeat of Sennacherib, ca. 1617, Alte Pinakothek, Munich. Pupil of Rembrandt, The Adoration of the Shepherds, 1646, The National Gallery, London. Pieter Bruegel the Elder, The Adoration of the Kings, 1564, The National Gallery, London.

Send us a textIn this episode of the FuturePrint Podcast, Marcus Timson is joined once again by Rob Karsten, who leads the print business for Excelitas in Europe. Rob has been a long-standing advocate of LED curing in print, and since the acquisition of Phoseon his remit has expanded to cover the full Excelitas portfolio: UV, IR, excimer and LED technologies.The conversation sets the scene for Rob's upcoming talk at FuturePrint Industrial Print in Munich, where he will explore how AI and sustainability can work together to transform packaging and industrial print.Rob explains how the move from traditional mercury UV systems to digital LED curing is not only reducing energy consumption, but also generating richer process data. That data, in turn, is the fuel for AI-driven improvements in yield, scrap reduction and process stability. Sustainability, he argues, is no longer just about energy labels - it is about running smarter, more efficient factories end to end.He outlines the key domains where AI can make a tangible difference today, from material optimisation and packaging design through to predictive maintenance, smart energy use, logistics and inventory management. Rob also talks about the importance of prioritising: not all AI projects are equal, and businesses need to start where return on investment and environmental benefit are easiest to see and measure.Crucially, he challenges the assumption that sustainability and profitability always conflict. When you treat sustainability as a question of yield, waste and process efficiency, AI and data become powerful tools for improving both environmental outcomes and the bottom line. At the same time, he cautions that AI itself has an energy footprint, and that the industry will need to think systemically about net impact.Finally, Rob shares a preview of his AI for Industrial Print session in Munich, which will provide a practical roadmap for ranking AI opportunities in packaging and print, and highlight where the “big wins” really are.Listen on:Apple PodcastGoogle PodcastSpotifyWhat is FuturePrint? FuturePrint is a digital and in person platform and community dedicated to future print technology. Over 20,000 people per month read our articles, listen to our podcasts, view our TV features, click on our e-newsletters and attend our in-person and virtual events. We hope to see you at one of our future in-person events:FuturePrint TECH: Industrial Print: 21-22 January '26, Munich, Germany

I am Rolf Claessen and together with my co-host Ken Suzan I am welcoming you to episode 169 of our podcast IP Fridays! Today's interview guest is Prof. Aloys Hüttermann, co-founder of my patent law firm Michalski Hüttermann & Partner and a true expert on the Unified Patent Court. He has written several books about the new system and we talk about all the things that plaintiffs and defendants can learn from the first decisions of the court and what they mean for strategic decisions of the parties involved. But before we jump into this very interesting interview, I have news for you! The US Patent and Trademark Office (USPTO) is planning rule changes that would make it virtually impossible for third parties to challenge invalid patents before the patent office. Criticism has come from the EFF and other inventor rights advocates: the new rules would play into the hands of so-called non-practicing entities (NPEs), as those attacked would have few cost-effective ways to have questionable patents deleted. The World Intellectual Property Organization (WIPO) reports a new record in international patent applications: in 2024, around 3.7 million patent applications were filed worldwide – an increase of 4.9% over the previous year. The main drivers were Asian countries (China alone accounted for 1.8 million), while demand for trademark protection has stabilized after the pandemic decline. US rapper Eminem is taking legal action in Australia against a company that sells swimwear under the name “Swim Shady.” He believes this infringes on his famous “Slim Shady” brand. The case illustrates that even humorous allusions to well-known brand names can lead to legal conflicts. A new ruling by the Unified Patent Court (UPC) demonstrates its cross-border impact. In “Fujifilm v. Kodak,” the local chamber in Mannheim issued an injunction that extends to the UK despite Brexit. The UPC confirmed its jurisdiction over the UK parts of a European patent, as the defendant Kodak is based in a UPC member state. A dispute over standard patents is looming at the EU level: the Legal Affairs Committee (JURI) of the European Parliament voted to take the European Commission to the European Court of Justice. The reason for this is the Commission’s controversial withdrawal of a draft regulation on the licensing of standard-essential patents (SEPs). Parliament President Roberta Metsola is to decide by mid-November whether to file the lawsuit. In trademark law, USPTO Director Squires reported on October 31, 2025, that a new unit (“Trademark Registration Protection Office”) had removed approximately 61,000 invalid trademark applications from the registries. This cleanup of the backlog relieved the examining authority and accelerated the processing of legitimate applications. Now let's jump into the interview with Aloys Hüttermann: The Unified Patent Court Comes of Age – Insights from Prof. Aloys Hüttermann The Unified Patent Court (UPC) has moved from a long-discussed project to a living, breathing court system that already shapes patent enforcement in Europe. In a recent IP Fridays interview, Prof. Aloys Hüttermann – founder and equity partner at Michalski · Hüttermann & Partner and one of the earliest commentators on the UPC – shared his experiences from the first years of practice, as well as his view on how the UPC fits into the global patent litigation landscape. This article summarises the key points of that conversation and is meant as an accessible overview for in-house counsel, patent attorneys and business leaders who want to understand what the UPC means for their strategy. How Prof. Hüttermann Became “Mr. UPC” Prof. Hüttermann has been closely involved with the UPC for more than a decade. When it became clear, around 13 years ago, that the European project of a unified patent court and a unitary patent was finally going to happen, he recognised that this would fundamentally change patent enforcement in Europe. He started to follow the legislative and political developments in detail and went beyond mere observation. As author and editor of several books and a major commentary on the UPC, he helped shape the discussion around the new system. His first book on the UPC appeared in 2016 – years before the court finally opened its doors in 2023. What fascinated him from the beginning was the unique opportunity to witness the creation of an entirely new court system, to analyse how it would be built and, where possible, to contribute to its understanding and development. It was clear to him that this system would be a “game changer” for European patent enforcement. UPC in the Global Triangle: Europe, the US and China In practice, most international patent disputes revolve around three major regions: the UPC territory in Europe, the United States and China. Each of these regions has its own procedural culture, cost structure and strategic impact. From a territorial perspective, the UPC is particularly attractive because it can, under the right conditions, grant pan-European injunctions that cover a broad range of EU Member States with a single decision. This consolidation of enforcement is something national courts in Europe simply cannot offer. From a cost perspective, the UPC is significantly cheaper than US litigation, especially if one compares the cost of one UPC action with a bundle of separate national cases in large European markets. When viewed against the territorial reach and procedural speed, the “bang for the buck” is very compelling. China is again a different story. The sheer volume of cases there is enormous, with tens of thousands of patent infringement cases per year. Chinese courts are known for their speed; first-instance decisions within about a year are common. In this respect they resemble the UPC more than the US does. The UPC also aims at a roughly 12 to 15 month time frame for first-instance cases where validity is at issue. The US, by contrast, features extensive discovery, occasionally jury trials and often longer timelines. The procedural culture is very different. The UPC, like Chinese courts, operates without discovery in the US sense, which makes proceedings more focused on the written record and expert evidence that the parties present, and less on pre-trial disclosure battles. Whether a company chooses to litigate in the US, the UPC, China, or some combination of these forums will depend on where the key markets and assets are. However, in Prof. Hüttermann's view, once Europe is an important market, it is hard to justify ignoring the UPC. He expects the court's caseload and influence to grow strongly over the coming years. A Landmark UPC Case: Syngenta v. Sumitomo A particularly important case in which Prof. Hüttermann was involved is the Syngenta v. Sumitomo matter, concerning a composition patent. This case has become a landmark in UPC practice for several reasons. First, the Court of Appeal clarified a central point about the reach of UPC injunctions. It made clear that once infringement is established in one Member State, this will usually be sufficient to justify a pan-European injunction covering all UPC countries designated by the patent. That confirmation gave patent owners confidence that the UPC can in fact deliver broad, cross-border relief in one go. Second, the facts of the case raised novel issues about evidence and territorial reach. The allegedly infringing product had been analysed based on a sample from the Czech Republic, which is not part of the UPC system. Later, the same product with the same name was marketed in Bulgaria, which is within UPC territory. The Court of Appeal held that the earlier analysis of the Czech sample could be relied on for enforcement in Bulgaria. This showed that evidence from outside the UPC territory can be sufficient, as long as it is properly linked to the products marketed within the UPC. Third, the Court of Appeal took the opportunity to state its view on inventive step. It confirmed that combining prior-art documents requires a “pointer”, in line with the EPO's problem-solution approach. The mere theoretical possibility of extracting a certain piece of information from a document does not suffice to justify an inventive-step attack. This is one of several decisions where the UPC has shown a strong alignment with EPO case law on substantive patentability. For Prof. Hüttermann personally, the case was also a lesson in oral advocacy before the UPC. During the two appeal hearings, the presiding judge asked unexpected questions that required quick and creative responses while the hearing continued. His practical takeaway is that parties should appear with a small, well-coordinated team: large enough to allow someone to work on a tricky question in the background, but small enough to remain agile. Two or three lawyers seem ideal; beyond that, coordination becomes difficult and “too many cooks spoil the broth”. A Game-Changing CJEU Decision: Bosch Siemens Hausgeräte v. Electrolux Surprisingly, one of the most important developments for European patent litigation in the past year did not come from the UPC at all, but from the Court of Justice of the European Union. In Bosch Siemens Hausgeräte v. Electrolux, the CJEU revisited the rules on cross-border jurisdiction under the Brussels I Recast Regulation (Brussels Ia). Previously, under what practitioners often referred to as the GAT/LuK regime, a court in one EU country was largely prevented from granting relief for alleged infringement in another country if the validity of the foreign patent was contested there. This significantly limited the possibilities for cross-border injunctions. In Bosch, the CJEU changed course. Without going into all procedural details, the essence is that courts in the EU now have broader powers to grant cross-border relief when certain conditions are met, particularly when at least one defendant is domiciled in the forum state. The concept of an “anchor defendant” plays a central role: if you sue one group company in its home forum, other group companies in other countries, including outside the EU, can be drawn into the case. This has already had practical consequences. German courts, for example, have issued pan-European injunctions covering around twenty countries in pharmaceutical cases. There are even attempts to sue European companies for infringement of US patents based on acts in the US, using the logic of Bosch as a starting point. How far courts will ultimately go remains to be seen, but the potential is enormous. For the UPC, this development is highly relevant. The UPC operates in the same jurisdictional environment as national courts, and many defendants in UPC cases will be domiciled in UPC countries. This increases the likelihood that the UPC, too, can leverage the broadened possibilities for cross-border relief. In addition, we have already seen UPC decisions that include non-EU countries such as the UK within the scope of injunctions, in certain constellations. The interaction between UPC practice and the Bosch jurisprudence of the CJEU is only beginning to unfold. Does the UPC Follow EPO Case Law? A key concern for many patent owners and practitioners is whether the UPC will follow the EPO's Boards of Appeal or develop its own, possibly divergent, case law on validity. On procedural matters, the UPC is naturally different from the EPO. It has its own rules of procedure, its own timelines and its own tools, such as “front-loaded” pleadings and tight limits on late-filed material. On substantive law, however, Prof. Hüttermann's conclusion is clear: there is “nothing new under the sun”. The UPC's approach to novelty, inventive step and added matter is very close to that of the EPO. The famous “gold standard” for added matter appears frequently in UPC decisions. Intermediate generalisations are treated with the same suspicion as at the EPO. In at least one case, the UPC revoked a patent for added matter even though the EPO had granted it in exactly that form. The alignment is not accidental. The UPC only deals with European patents granted by the EPO; it does not hear cases on purely national patents. If the UPC were more generous than the EPO, many patents would never reach it. If it were systematically stricter, patentees would be more tempted to opt out of the system. In practice, the UPC tends to apply the EPO's standards and, where anything differs, it is usually a matter of factual appreciation rather than a different legal test. For practitioners, this has a very practical implication: if you want to predict how the UPC will decide on validity, the best starting point is to ask how the EPO would analyse the case. The UPC may not always reach the same result in parallel EPO opposition proceedings, but the conceptual framework is largely the same. Trends in UPC Practice: PIs, Equivalents and Division-Specific Styles Even in its early years, certain trends and differences between UPC divisions can be observed. On preliminary injunctions, the local division in Düsseldorf has taken a particularly proactive role. It has been responsible for most of the ex parte PIs granted so far and applies a rather strict notion of urgency, often considering one month after knowledge of the infringement as still acceptable, but treating longer delays with scepticism. Other divisions tend to see two months as still compatible with urgency, and they are much more cautious with ex parte measures. Munich, by contrast, has indicated a strong preference for inter partes PI proceedings and appears reluctant to grant ex parte relief at all. A judge from Munich has even described the main action as the “fast” procedure and the inter partes PI as the “very fast” one, leaving little room for an even faster ex parte track. There are also differences in how divisions handle amendments and auxiliary requests in PI proceedings. Munich has suggested that if a patentee needs to rely on claim amendments or auxiliary requests in a PI, the request is unlikely to succeed. Other divisions have been more open to considering auxiliary requests. The doctrine of equivalents is another area where practice is not yet harmonised. The Hague division has explicitly applied a test taken from Dutch law in at least one case and found infringement by equivalence. However, the Court of Appeal has not yet endorsed a specific test, and in another recent Hague case the same division did not apply that Dutch-law test again. The Mannheim division has openly called for the development of an autonomous, pan-European equivalence test, but has not yet fixed such a test in a concrete decision. This is clearly an area to watch. Interim conferences are commonly used in most divisions to clarify issues early on, but Düsseldorf often dispenses with them to save time. In practice, interim conferences can be very helpful for narrowing down the issues, though parties should not expect to be able to predict the final decision from what is discussed there. Sometimes topics that dominate the interim conference play little or no role in the main oral hearing. A Front-Loaded System and Typical Strategic Mistakes UPC proceedings are highly front-loaded and very fast. A defendant usually has three months from service of the statement of claim to file a full statement of defence and any counterclaim for revocation. This is manageable, but only if the time is used wisely. One common strategic problem is that parties lose time at the beginning and only develop a clear strategy late in the three-month period. According to Prof. Hüttermann, it is crucial to have a firm strategy within the first two or three weeks and then execute it consistently. Constantly changing direction is a recipe for failure in such a compressed system. Another characteristic is the strict attitude towards late-filed material. It is difficult to introduce new documents or new inventive-step attacks later in the procedure. In some cases even alternative combinations of already-filed prior-art documents have been viewed as “new” attacks and rejected as late. At the appeal stage, the Court of Appeal has even considered new arguments based on different parts of a book already in the file as potentially late-filed. This does not mean that parties should flood the court with dozens of alternative attacks in the initial brief. In one revocation action, a plaintiff filed about fifty different inventive-step attacks, only to be told by the court that this was not acceptable and that the attacks had to be reduced and structured. The UPC is not a body conducting ex officio examination. It is entitled to manage the case actively and to ask parties to focus on the most relevant issues. Evidence Gathering, Protective Letters and the Defendant's Perspective The UPC provides powerful tools for both sides. Evidence inspection is becoming more common, not only at trade fairs but also at company premises. This can be a valuable tool for patentees, but it also poses a serious risk for defendants who may suddenly face court-ordered inspections. From the perspective of potential defendants, protective letters are an important instrument, especially in divisions like Düsseldorf where ex parte PIs are possible. A well-written protective letter, filed in advance, can significantly reduce the risk of a surprise injunction. The court fees are moderate, but the content of the protective letter must be carefully prepared; a poor submission can cause more harm than good. Despite the strong tools available to patentees, Prof. Hüttermann does not view the UPC as unfair to defendants. If a defendant files a solid revocation counterclaim, the pressure shifts to the patentee, who then has only two months to reply, prepare all auxiliary requests and adapt the enforcement strategy. This is even more demanding than at the EPO, because the patentee must not only respond to validity attacks but also ensure that any amended claims still capture the allegedly infringing product. It is entirely possible to secure the survival of a patent with an auxiliary request that no longer covers the defendant's product. In that scenario, the patentee has “won” on validity but lost the infringement case. Managing this tension under tight time limits is a key challenge of UPC practice. The Future Role of the UPC and How to Prepare Today the UPC hears a few hundred cases per year, compared with several thousand patent cases in the US and tens of thousands in China. Nevertheless, both the court itself and experienced practitioners see significant growth potential. Prof. Hüttermann expects case numbers to multiply in the medium term. Whether the UPC will become the first choice forum in global disputes or remain one pillar in parallel proceedings alongside the US and China will depend on the strategies of large patentees and the evolution of case law. However, the court is well equipped: it covers a large, economically important territory, is comparatively cost-effective and offers fast procedures with robust remedies. For companies that may end up before the UPC, preparation is essential. On the offensive side, that means building strong evidence and legal arguments before filing, being ready to proceed quickly and structured, and understanding the specific styles of the relevant divisions. On the defensive side, it may mean filing protective letters in risk-exposed markets, preparing internal processes for rapid reaction if a statement of claim arrives, and taking inspection requests seriously. Conclusion The Unified Patent Court has quickly moved from theory to practice. It offers pan-European relief, fast and front-loaded procedures, and a substantive approach that closely mirrors the EPO's case law. At the same time, national and EU-level developments like the Bosch Siemens Hausgeräte v. Electrolux decision are reshaping the jurisdictional framework in which the UPC operates, opening the door for far-reaching cross-border injunctions. For patent owners and potential defendants alike, the message is clear: the UPC is here to stay and will become more important year by year. Those who invest the time to understand its dynamics now – including its alignment with the EPO, the differences between divisions, and the strategic implications of its procedures – will be in a much better position when the first UPC dispute lands on their desk. Here is the full transcript of the interview: Rolf Claessen:Today's interview guest is Prof. Aloys Hüttermann. He is founder and equity partner of my firm, Michalski · Hüttermann & Partner. More importantly for today's interview, he has written several books about the Unified Patent Court. The first one already came out in 2016. He is co-editor and author of one of the leading commentaries on the UPC and has gained substantial experience in UPC cases so far – one of them even together with me. Thank you very much for being on IP Fridays again, Aloys. Aloys Hüttermann:Thank you for inviting me, it's an honour. How did you get so deeply involved in the UPC? Rolf Claessen:Before we dive into the details, how did you end up so deeply involved in the Unified Patent Court? And what personally fascinates you about this court? Aloys Hüttermann:This goes back quite a while – roughly 13 years. At that time it became clear that, after several failed attempts, Europe would really get a pan-European court and a pan-European patent, and that this time it was serious. I thought: this is going to be the future. That interested me a lot, both intellectually and practically. A completely new system was being built. You could watch how it evolved – and, if possible, even help shape it a bit. It was also obvious to me that this would be a complete game changer. Nobody expected that it would take until 2023 before the system actually started operating, but now it is here. I became heavily interested early on. As you mentioned, my first book on the UPC was published in 2016, in the expectation that the system would start soon. It took a bit longer, but now we finally have it. UPC vs. US and China – speed, cost and impact Rolf Claessen:Before we go deeper into the UPC, let's zoom out. If you compare litigation before the UPC with patent litigation in the US and in China – in terms of speed, cost and the impact of decisions – what are the key differences that a business leader should understand? Aloys Hüttermann:If you look at the three big regions – the UPC territory in Europe, the US and China – these are the major economic areas for many technology companies. One important point is territorial reach. In the UPC, if the conditions are met, you can get pan-European injunctions that cover many EU Member States in one go. We will talk about this later in more detail. On costs there is a huge difference between the US and the UPC. The UPC is much cheaper than US litigation, especially once you look at the number of countries you can cover with one case if the patent has been validated widely. China is different again. The number of patent infringement cases there is enormous. I have seen statistics of around 40,000 infringement cases per year in China. That is huge – compared with roughly 164 UPC infringement cases in the first year and maybe around 200 in the current year. On speed, Chinese courts are known to be very fast. You often get a first-instance decision in about a year. The UPC is comparable: if there is a counterclaim for revocation, you are looking at something like 12 to 15 months for a first-instance decision. The US can be slower, and the procedure is very different. You have full discovery, you may have juries. None of that exists at the UPC. From that perspective, Chinese and UPC proceedings are more similar to each other than either is to the US. The UPC is still a young court. We have to see how influential its case law will be worldwide in the long run. What we already see, at least in Germany, is a clear trend away from purely national patent litigation and towards the UPC. That is inside Europe. The global impact will develop over time. When is the UPC the most powerful tool? Rolf Claessen:Let's take the perspective of a global company. It has significant sales in Europe and in the US and production or key suppliers in China. In which situations would you say the UPC is your most powerful tool? And when might the US or China be the more strategic battleground? Aloys Hüttermann:To be honest, I would almost always consider bringing a case before the UPC. The “bang for the buck” is very good. The UPC is rather fast. That alone already gives you leverage in negotiations. The threat of a quick, wide-reaching injunction is a strong negotiation tool. Whether you litigate in the US instead of the UPC, or in addition, or whether you also go to China – that depends heavily on the individual case: where the products are sold, where the key markets are, where the defendant has assets, and so on. But in my view, once you have substantial sales in Europe, you should seriously consider the UPC. And for that reason alone I expect case numbers at the UPC to increase significantly in the coming years. A landmark UPC case: Syngenta vs. Sumitomo (composition patent) Rolf Claessen:You have already been involved in several UPC cases – and one of them together with me, which was great fun. Looking at the last 12 to 18 months, is there a case, decision or development that you find particularly noteworthy – something that really changed how you think about UPC litigation or how companies should prepare? Aloys Hüttermann:The most important UPC case I have been involved in so far is the Syngenta v. Sumitomo case on a composition patent. It has become a real landmark and was even mentioned in the UPC's annual report. It is important for several reasons. First, it was one of the first cases in which the Court of Appeal said very clearly: if you have established infringement in one Member State, that will usually be enough for a pan-European injunction covering all UPC countries designated by the patent. That is a powerful statement about the reach of UPC relief. Second, the facts were interesting. The patent concerned a composition. We had analysed a sample that had been obtained in the Czech Republic, which is not a UPC country. Later, the same product was marketed under the same name in Bulgaria, which is in the UPC. The question was whether the analysis of the Czech sample could be used as a basis for enforcement in Bulgaria. The Court of Appeal said yes, that was sufficient. Third, the Court of Appeal took the opportunity to say something about inventive step. It more or less confirmed that the UPC's approach is very close to the EPO's problem-solution approach. It emphasised that, if you want to combine prior-art documents, you need a “pointer” to do so. The mere theoretical possibility that a skilled person could dig a particular piece of information out of a document is not enough. For me personally, the most memorable aspect of this case was not the outcome – that was largely in line with what we had expected – but the oral hearings at the appeal stage. We had two hearings. In both, the presiding judge asked us a question that we had not anticipated at all. And then you have about 20 minutes to come up with a convincing answer while the hearing continues. We managed it, but it made me think a lot about how you should prepare for oral hearings at the UPC. My conclusion is: you should go in with a team, but not too big. In German we say, “Zu viele Köche verderben den Brei” – too many cooks spoil the broth. Two or three people seems ideal. One of them can work quietly on such a surprise question at the side, while the others continue arguing the case. In the end the case went very well for us, so I can speak about it quite calmly now. But in the moment your heart rate definitely goes up. The CJEU's Bosch Siemens Hausgeräte v. Electrolux decision – a real game changer Rolf Claessen:You also mentioned another development that is not even a UPC case, but still very important for European patent litigation. Aloys Hüttermann:Yes. In my view, the most important case of the last twelve months is not a UPC decision but a judgment of the Court of Justice of the EU (CJEU): Bosch Siemens Hausgeräte v. Electrolux. This is going to be a real game changer for European IP law, and I am sure we have not seen the end of its effects yet. One example: someone has recently sued BMW before the Landgericht München I, a German court, for infringement of a US patent based on acts in the US. The argument is that this could be backed by the logic of Bosch Siemens Hausgeräte v. Electrolux. We do not know yet what the court will do with that, but the fact that people are trying this shows how far-reaching the decision might be. Within the UPC we have already seen injunctions being issued for countries outside the UPC territory and even outside the EU, for example including the UK. So you see how these developments start to interact. Rolf Claessen:For listeners who have not followed the case so closely: in very simple terms, the CJEU opened the door for courts in one EU country to rule on patent infringement that took place in other countries as well, right? Aloys Hüttermann:Exactly. Before Bosch Siemens Hausgeräte v. Electrolux we had what was often called the GAT/LuK regime. The basic idea was: if you sue someone in, say, Germany for infringement of a European patent, and you also ask for an injunction for France, and the defendant then challenges the validity of the patent in France, the German court cannot grant you an injunction covering France. The Bosch decision changed that. The legal basis is the Brussels I Recast Regulation (Brussels Ia), which deals with jurisdiction in civil and commercial matters in the EU. It is not specific to IP; it applies to civil cases generally, but it does have some provisions that are relevant for patents. In Bosch, a Swedish court asked the CJEU for guidance on cross-border injunctions. The CJEU more or less overturned its old GAT/LuK case law. Now, in principle, if the defendant is domiciled in a particular Member State, the courts of that state can also grant cross-border relief for other countries, under certain conditions. We will not go into all the details here – that could fill a whole separate IP Fridays episode – but one important concept is the “anchor defendant”. If you sue a group of companies and at least one defendant is domiciled in the forum state, then other group companies in other countries – even outside the EU, for example in Hong Kong – can be drawn into the case and affected by the decision. This is not limited to the UPC, but of course it is highly relevant for UPC litigation. Statistically it increases the chances that at least one defendant will be domiciled in a UPC country, simply because there are many of them. And we have already seen courts like the Landgericht München I grant pan-European injunctions for around 20 countries in a pharmaceutical case. Rolf Claessen:Just to clarify: does it have to be the headquarters of the defendant in that country, or is any registered office enough? Aloys Hüttermann:That is one of the open points. If the headquarters are in Europe, then it is clear that subsidiaries outside Europe can be affected as well. If the group's headquarters are outside Europe and only a subsidiary is here, the situation is less clear and we will have to see what the courts make of it. Does the UPC follow EPO case law? Rolf Claessen:Many patent owners and in-house counsel wonder: does the UPC largely follow the case law of the EPO Boards of Appeal, or is it starting to develop its own distinct line? What is your impression so far – both on substantive issues like novelty and inventive step, and on procedural questions? Aloys Hüttermann:On procedure the UPC is, of course, very different. It has its own procedural rules and they are not the same as at the EPO. If we look at patent validity, however, my impression is that there is “nothing new under the sun” – that was the title of a recent talk I gave and will give again in Hamburg. Substantively, the case law of the UPC and the EPO is very similar. For inventive step, people sometimes say the UPC does not use the classical problem-solution approach but a more “holistic” approach – whatever that is supposed to mean. In practice, in both systems you read and interpret prior-art documents and decide what they really disclose. In my view, the “error bar” that comes from two courts simply reading a document slightly differently is much larger than any systematic difference in legal approach. If you look at other grounds, such as novelty and added matter, the UPC even follows the EPO almost verbatim. The famous “gold standard” for added matter appears all over UPC decisions, even if the EPO case numbers are not always cited. The same is true for novelty. So the rule-based, almost “Hilbertian” EPO approach is very much present at the UPC. There is also a structural reason for that. All patents that the UPC currently deals with have been granted by the EPO. The UPC does not handle patents granted only by national offices. If the UPC wanted to deviate from EPO case law and be more generous, then many patents would never reach the UPC in the first place. The most generous approach you can have is the one used by the granting authority – the EPO. So if the UPC wants to be different, it can only be stricter, not more lenient. And there is little incentive to be systematically stricter, because that would reduce the number of patents that are attractive to enforce before the UPC. Patent owners might simply opt out. Rolf Claessen:We also talked about added matter and a recent case where the Court of Appeal was even stricter than the EPO. That probably gives US patent practitioners a massive headache. They already struggle with added-matter rules in Europe, and now the UPC might be even tougher. Aloys Hüttermann:Yes, especially on added matter. I once spoke with a US practitioner who said, “We hope the UPC will move away from intermediate generalisations.” There is no chance of that. We already have cases where the Court of Appeal confirmed that intermediate generalisations are not allowed, in full alignment with the EPO. You mentioned a recent case where a patent was revoked for added matter, even though it had been granted by the EPO in exactly that form. This shows quite nicely what to expect. If you want to predict how the UPC will handle a revocation action, the best starting point is to ask: “What would the EPO do?” Of course, there will still be cases where the UPC finds an invention to be inventive while the EPO, in parallel opposition proceedings, does not – or vice versa. But those are differences in the appreciation of the facts and the prior art, which you will always have. The underlying legal approach is essentially the same. Rolf Claessen:So you do not see a real example yet where the UPC has taken a totally different route from the EPO on validity? Aloys Hüttermann:No, not really. If I had to estimate how the UPC will decide, I would always start from what I think the EPO would have done. Trends in UPC practice: PIs, equivalents, interim conferences Rolf Claessen:If you look across the different UPC divisions and cases: what trends do you see in practice? For example regarding timelines, preliminary injunctions, how validity attacks are handled, and how UPC cases interact with EPO oppositions or national proceedings? Aloys Hüttermann:If you take the most active divisions – essentially the big four in Germany and the local division in The Hague – they all try to be very careful and diligent in their decisions. But you can already see some differences in practice. For preliminary injunctions there is a clear distinction between the local division in Düsseldorf and most other divisions. Düsseldorf considers one month after knowledge of the infringement as still sufficiently urgent. If you wait longer, it is usually considered too late. In many other divisions, two months is still viewed as fine. Düsseldorf has also been the division that issued most of the ex parte preliminary injunctions so far. Apart from one special outlier where a standing judge from Brussels was temporarily sitting in Milan, Düsseldorf is basically the only one. Other divisions have been much more reluctant. At a conference, Judge Pichlmaier from the Munich division once said that he could hardly imagine a situation where his division would grant an ex parte PI. In his words, the UPC has two types of procedure: one that is fast – the normal main action – and one that is very fast – the inter partes PI procedure. But you do not really have an “ultra-fast” ex parte track, at least not in his division. Another difference relates to amendments and auxiliary requests in PI proceedings. In one recent case in Munich the court said more or less that if you have to amend your patent or rely on auxiliary requests in a PI, you lose. Other divisions have been more flexible and have allowed auxiliary requests. Equivalence is another area where we do not have a unified line yet. So far, only the Hague division has clearly found infringement under the doctrine of equivalents and explicitly used a test taken from Dutch law. Whether that test will be approved by the Court of Appeal is completely open – the first case settled, so the Court of Appeal never ruled on it, and a second one is still very recent. Interestingly, there was another Hague decision a few weeks ago where equivalence was on the table, but the division did not apply that Dutch-law test. We do not know yet why. The Mannheim division has written in one decision that it would be desirable to develop an autonomous pan-European test for equivalence, instead of just importing the German, UK or Dutch criteria. But they did not formulate such a test in that case because it was not necessary for the decision. So we will have to see how that evolves. On timelines, one practical difference is that Düsseldorf usually does not hold an interim conference. That saves them some time. Most other divisions do hold interim conferences. Personally, I like the idea because it can help clarify issues. But you cannot safely read the final outcome from these conferences. I have also seen cases where questions raised at the interim conference did not play any role in the main oral hearing. So they are useful for clarification, but not as a crystal ball. Front-loaded proceedings and typical strategic mistakes Rolf Claessen:If you look at the behaviour of parties so far – both patentees and defendants – what are the most common strategic mistakes you see in UPC litigation? And what would a well-prepared company do differently before the first statement of claim is ever filed? Aloys Hüttermann:You know you do not really want me to answer that question… Rolf Claessen:I do! Aloys Hüttermann:All right. The biggest mistake, of course, is that they do not hire me. That is the main problem. Seriously, it is difficult to judge parties' behaviour from the outside. You rarely know the full picture. There may be national proceedings, licensing discussions, settlement talks, and so on in the background. That can limit what a party can do at the UPC. So instead of criticising, I prefer to say what is a good idea at the UPC. The system is very front-loaded and very fast. If you are sued, you have three months to file your statement of defence and your counterclaim for revocation. In my view, three months are manageable – but only if you use the time wisely and do not waste it on things that are not essential. If you receive a statement of claim, you have to act immediately. You should have a clear strategy within maybe two or three weeks and then implement it. If you change your strategy every few weeks, chances are high that you will fail. Another point is that everything is front-loaded. It is very hard to introduce new documents or new attacks later. Some divisions have been a bit generous in individual cases, but the general line is strict. We have seen, for example, that even if you filed a book in first instance, you may not be allowed to rely on a different chapter from the same book for a new inventive-step attack at the appeal stage. That can be regarded as late-filed, because you could have done it earlier. There is also case law saying that if you first argue inventive step as “D1 plus D2”, and later want to argue “D2 plus D1”, that can already be considered a new, late attack. On the other hand, we had a revocation action where the plaintiff filed about 50 different inventive-step attacks in the initial brief. The division then said: this does not work. Please cut them down or put them in a clear hierarchy. In the end, not all of them were considered. The UPC does not conduct an ex officio examination. It is entitled to manage the case and to tell the parties to limit themselves in the interest of a fair and efficient procedure. Rolf Claessen:I have the feeling that the EPO is also becoming more front-loaded – if you want to rely on documents later, you should file them early. But it sounds like the UPC is even more extreme in that regard. Aloys Hüttermann:Yes, that is true. Protective letters, inspections and the defendant's perspective Rolf Claessen:Suppose someone from a company is listening now and thinks: “We might be exposed at the UPC,” or, “We should maybe use the UPC offensively against competitors.” What would you consider sensible first steps before any concrete dispute arises? And looking three to five years ahead, how central do you expect the UPC to become in global patent litigation compared to the US and China? Aloys Hüttermann:Let me start with the second part. I expect the UPC to become significantly more important. If we have around 200 cases this year, that is a good start, but it is still very small compared to, say, 4,000 to 5,000 patent cases per year in the US and 40,000 or so in China. Even François Bürgin and Klaus Grabinski, in interviews, have said that they are happy with the case load, but the potential is much larger. In my view, it is almost inevitable that we will see four or five times as many UPC cases in the not-too-distant future. As numbers grow, the influence of the UPC will grow as well. Whether, in five or ten years, companies will treat the UPC as their first choice forum – or whether they will usually run it in parallel with US litigation in major disputes – remains to be seen. The UPC would be well equipped for that: the territory it covers is large, Europe is still an important economy, and the UPC procedure is very attractive from a company's perspective. On sensible first steps: if you are worried about being sued, a protective letter can make a lot of sense – especially in divisions like Düsseldorf, where ex parte PIs are possible in principle. A protective letter is not very expensive in terms of court fees. There is also an internal system that ensures the court reads it before deciding on urgent measures. Of course, the content must have a certain quality; a poor protective letter can even backfire. If you are planning to sue someone before the UPC, you should be extremely well prepared when you file. You should already have all important documents and evidence at hand. As we discussed, it is hard to introduce new material later. One tool that is becoming more and more popular is inspection – not just at trade fairs, where we already saw cases very early, but also at company premises. Our firm has already handled such an inspection case. That is something you should keep in mind on both sides: it is a powerful evidence-gathering tool, but also a serious risk if you are on the receiving end. From the defendant's perspective, I do not think the UPC is unfair. If you do your job properly and put a solid revocation counterclaim on the table, then the patentee has only two months to prepare a full reply and all auxiliary requests. And there is a twist that makes life even harder for the patentee than at the EPO. At the EPO the question is mainly: do my auxiliary requests overcome the objections and are they patentable? At the UPC there is an additional layer: do I still have infringement under the amended claims? You may save your patent with an auxiliary request that no longer reads on the defendant's product. That is great for validity, but you have just lost the infringement case. You have kept the patent but lost the battle. And all of this under very tight time limits. That creates considerable pressure on both sides. How to contact Prof. Hüttermann Rolf Claessen:Thank you very much for this really great interview, Aloys. Inside our firm you have a nickname: “the walking encyclopedia of the Unified Patent Court” – because you have written so many books about it and have dealt with the UPC for such a long time. What is the best way for listeners to get in touch with you? Aloys Hüttermann:The easiest way is by email. You can simply write to me, and that is usually the best way to contact me. As you may have noticed, I also like to speak. I am a frequent speaker at conferences. If you happen to be at one of the conferences where I am on the programme – for example, next week in Hamburg – feel free to come up to me and ask me anything in person. But email is probably the most reliable first step. Rolf Claessen:Perfect. Thank you very much, Aloys. Aloys Hüttermann:Thank you. It was a pleasure to be on IP Fridays again. Some of your long-time listeners may remember that a few years ago – when you were not yet part of our firm – we already did an episode on the UPC, back when everything was still very speculative. It is great to be back now that the system is actually in place and working. Rolf Claessen:I am very happy to have you back on the show.

Susanne Heipcke is Director of Software Engineering at FICO, where she has led the Modelling Team of FICO Xpress development for more than 12 years. Her team is responsible for the development and design of the modelling tools (Xpress Mosel) and the APIs of the Xpress Optimization software suite, with past tasks including the design of application development toolkits, solution templates, and productized optimization solutions such as FICO Decision Optimizer. More recently, her team's responsibilities have expanded to include CI/CD, performance testing, and delivery infrastructure for the entire Xpress suite. Before joining Dash Optimization (acquired by FICO in 2008) in 1998, she worked for BASF-AG in Germany. Her Ph.D. research at the University of Buckingham—conducted partly at the MIT OR Center (USA) and the University Aix-Marseille II (France)—focused on solving large-scale industrial problems using a combination of constraint programming and mixed integer programming. Her work centers on all aspects of modelling, particularly through her contributions to the development of the algebraic modelling and programming language Xpress Mosel. She is the author of the book Applications of Optimization with Xpress-MP and numerous papers on different aspects of mathematical modelling. Susanne enjoys teaching mathematical optimization, having participated in teaching the mathematical modelling course in the OR master's program at the University Aix-Marseille II (2001–2004) and the Computational Mixed-Integer Programming course at the Technical University of Munich in 2020. She regularly organizes specialist training events and conference sessions, such as the “Software for Optimization Modeling and Deployment” sessions at recent INFORMS Annual Meetings (jointly with Bob Fourer), and she is actively engaged in mentoring younger colleagues. Since 2019 she has been a member of the EURO Practitioners' Forum committee (formerly the EURO Working Group Practice of OR), leading the organization of the Forum's annual meetings in 2020, 2023, and 2026. With more than 30 years of experience in applied OR, she has also contributed to numerous consulting projects worldwide, involving scheduling and planning in manufacturing, personnel staffing, aircraft routing with maintenance planning, portfolio optimization, trading, energy production planning and unit commitment, and retail logistics.Contents of this video:0:00 - Intro1:27 - Family background and early years4:15 - Attending a girls' high school4:58 - Polyglot9:11 - Learning to program during high school11:13 - Moving to Bavaria to study mathematics13:19 - Practical data processing projects14:52 - Learning about OR16:31 - Master's thesis on constraint programming (CP) applied to a problem arising at BASF20:31 - Getting inspiration from a female leader at BASF22:14 - Spending half a year at the MIT OR Center + moving to the University of Buckingham for a PhD25:02 - Adapting to the UK26:06 - Combining MIP and CP to solve production planning and scheduling problems29:19 - Joining Dash Optimization in 199830:32 - Moving to France in 199931:20 - Working form home in an era before Zoom, Git, and similar tools existed32:28 - Maternity and work33:55 - The modelling language Xpress Mosel36:38 - Launching Mosel in 200139:45 - Evolution of Mosel over the years45:16 - Mosel's long-standing team47:35 - High compatibility across different versions of Mosel 48:16 - Xpress Mosel is a free software since 201849:21 - Favorite contributions to Mosel53:21 - Software engineering and optimization58:20 - AI and optimization software1:01:12 - Organizing conferences, workshops and special sessions regarding optimization software1:03:25 - EURO Practitioners' Forum1:04:52 - Regrets?1:05:18 - Plans for the future1:06:15 - Inspiring takeaway message1:07:22 - Concluding remarks

Daiichi Sankyo has been pioneering ADCs since 2010, with a pipeline targeting over 30 indications and potentially reaching 400,000 patients.In today's episode I'm joined by Dr. Markus Kosch, Head of the EU Oncology Business Division at Daiichi Sankyo. A physician by training with a deep academic background in oncology, Markus has spent over two decades advancing cancer care, from clinical practice to leadership roles shaping strategy across Europe and Canada. Since joining Daiichi Sankyo in 2021, he has been at the forefront of one of the industry's most ambitious ADC pipelines, overseeing more than 60 clinical trials across 24 countries and driving landmark approvals that are redefining treatment in breast, lung, and gastric cancers.This week's episode is brought to you with the support of Kadans. Looking for the perfect space to grow your Life Sciences company? Kadans Science Partner is Europe's leading provider of cutting-edge lab and offices spaces, tailored to your needs. Kadans puts you at the centre of innovation, giving you the chance to connect with top researchers, universities, and investors through its international network. Here, you'll join a vibrant community of innovators driving real change. Are you ready to take your research to the next level? Learn more at kadans.com – where innovation thrives. 01:45.         Meet Markus Kosch03:12.         Clinical background shaping an industry role04:46.         Daiichi Sankyo's 40-year oncology legacy06:19.         European investments and Munich hub10:34.         ADC platform strengths explained14:20.         Key ESMO 2025 trial dataClarification: The reference to ‘TB01' at 16:24 refers to the TROPION-Breast02 clinical trial, not TB01.19:43.         Managing risks and partnerships23:35.         Patient advocacy in trial design33:59.         Future of oncology and ADCsInterested in being a sponsor of an episode of our podcast? Discover how you can get involved here! Stay updated by subscribing to our newsletterTo dive deeper into the topic: 10 oncology deals in 2025 spotlight where industry leaders are betting bigAstraZeneca and Daiichi Sankyo's Enhertu recommended for approvalTen drugs to watch in 2025: will these therapies become blockbusters?

⚠️ Trigger Warning: This episode discusses suicide and assisted suicide. If these topics are upsetting or activating for you, please take care while listening. You may choose to skip this episode or reach out to someone you trust or a mental health resource for support. Alice and Ellen Kessler were identical twin sisters whose synchronized dance moves, glamour, and charisma made them stars across Europe and beyond. Born in 1936, the twins trained in ballet in East Germany. In 1952, their family fled to West Germany, and soon the sisters began dazzling audiences with their talent.  They rose to international fame in the 1950s and 60s: performing on cabaret stages, television variety shows, and even sharing the screen with legendary names like Frank Sinatra and Fred Astaire. Their elegant presence earned them the nickname "the legs of the nation." In November 2025, at the age of 89, Alice and Ellen made the deeply personal decision to end their lives together by joint assisted suicide in their home near Munich — a choice they had discussed and planned for over a long period. Follow us on IG: @homance_chronicles Connect with us: linktr.ee/homance Send us a Hoe of History request: homancepodcast@gmail.com

Arsenal beat Bayern 3–1 at the Emirates, and the lads jump on the mics straight after full-time for instant reaction. Gav, Ells and Jus break down the line-up, Bayern's early spell of control, Timber's opener, and 17-year-old Karl's equaliser before getting into how Arsenal completely took over the second half.There's praise for Rice, discussion on Lewis-Skelly's positioning, big love for Merino, and full chat on the game-changing impacts from Madueke, Calafiori and Martinelli as Arsenal closed out a huge Champions League win.Part 2 brings Who Am I?, the GW13 prediction game, and a Thanksgiving-themed Six Pack celebrating six reasons to be grateful for Arteta and the standards he's built.The episode closes with a detailed Chelsea preview — line-up debates, the Madueke vs Martinelli question, Odegaard's status, Calafiori's importance, Chelsea's threats (including Estevão and “Angry Matt Dillon” Neto) and what Sunday could mean for Arsenal's title position heading into December.Chapters:(00:00) – Arteta's Non-Negotiables Intro(01:40) – Line-Up Reaction(03:27) – Bayern's Early Possession(05:20) – Timber's Goal(07:09) – Saka Agendas(08:56) – Eze Chance Debate(10:21) – Bayern Equalise(11:37) – Skelly's Positioning Talk(13:46) – Half-Time Thoughts(15:45) – Rice Takes Over the Second Half(16:58) – Madueke In for Trossard / Missed Chances(19:51) – Noni's First Goal for Arsenal(22:08) – Calafiori Masterclass / Merino Flowers(24:50) – Martinelli's Goal(26:23) – By The Numbers: Arsenal Dominate(29:07) – PT.2 Who Am I? (Game)(30:27) – GW13 Prediction Game(33:35) – Six Pack (Arteta Thanksgiving Edition)(36:17) – Chelsea Preview(37:52) – Line-Up Debate: Martinelli, Noni or Trossard?(39:03) – Odegaard Decision: Start or Bench?(43:09) – Chelsea's Threats: Estevão & Angry Matt Dillon (Pedro Neto)(44:50) – Title Race Positioning After Bayern & Chelsea(46:35) – Arteta's Standards & Mentality Talk(49:51) – Who Am I (Game) Reveal & Sign-Off

A crowded server board with ten thousand parts doesn't forgive sloppy inspection—and neither do pricey GPUs and chiplets. From the floor of Productronica in Munich, we dig into how automated optical inspection keeps advanced packages honest once they hit the PCB line, where solder quality, coplanarity, and sheer component variety can make or break yield. Vidya Vijay from Nordson Test & Inspection joins us to unpack why AOI remains the fastest path to actionable insight, when X‑ray is the smarter choice, and how new sensor design changes the game for reflective, high‑mix assemblies.We explore the real pain points engineers face today: shiny dies that confuse cameras, BGAs packed with I/O where hidden defects hide under the body, and miniature passives that crowd tight keep‑outs. Vidya explains how three‑phase profilometry creates true 3D height maps by projecting fringe patterns and reading them from multiple angles, enabling precise checks for corner fill, underfill, and coplanarity. We also get into multi‑reflection suppression, Nordson's approach to filtering glare and ghost images so the system sees the joint, not the noise. With true RGB on side cameras and higher resolution, AOI can now pick out tiny solder balls and subtle surface issues at speed—fuel for stronger AI autoprogramming and more reliable defect classification.If throughput is king, data is queen. We talk about closing the loop from inspection back to the line to prevent bad lots—flagging stencil drift, placement offsets, and paste issues before they explode into scrap. Then we spotlight Nordson's launched SQ5000 Pro: faster cycle times, a wider field of view, and configurable 7 µm or 10 µm sensors designed for modern PCBA demands. Whether you're chasing yield on high‑value GPUs or balancing AOI with AXI on dense boards, this conversation offers a practical roadmap for choosing the right tool, tackling reflectivity, and using insight to drive predictable quality.Nordson Test and Inspection Delivering best-in-class test, inspection, and metrology solutions for semiconductor applications. Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the show

On this episode of Inside the Red and White Kate and friends are in Munich for the second Champions League away game. Great two goals shame we could keep the lead. Let's just focus on the sausages, beer and giant pretzels!!! Hosted on Acast. See acast.com/privacy for more information.

8 avril 1967, Munich. Le jeune Detliev Krämer, 16 ans, titube dans un tunnel grièvement blessé d'un coup de couteau. Il accuse un mystérieux "Freddy" d'avoir voulu le tuer. Mais plus la police enquête, plus l'histoire devient étrange. Les témoignages se contredisent, personne ne connaît ce “Freddy”, et le jeune Detliev semble avoir peur de dire la vérité. Que s'est-il vraiment passé cette nuit-là dans le Sentier Noir ?Pierre Bellemare raconte cette extraordinaire histoire dans cet épisode du podcast "Les récits extraordinaires de Pierre Bellemare", issu des archives d'Europe 1.Crédits :  Réalisation et composition musicale : Julien Tharaud Rédaction et production : Estelle LafontPatrimoine sonore : Sylvaine Denis, Laetitia Casanova, Antoine Reclus Création du visuel : Luowen Wang Remerciements à Roselyne Bellemare et Mariapia Bracchi-BellemareHébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

  Is the bitter war in Ukraine soon to wind down now that a peace settlement is being negotiated (think a Panmunjom-style compromise, not Munich-style appeasement), and how should America prepare for economic and military parity with China? In an episode devoted solely to viewers' questions, Hoover senior fellows Sir Niall Ferguson, John Cochrane and H.R. McMaster delve into matters ranging from those somber (allaying twenty-somethings' climate alarmism, “ideal” interest rates, the future of tank warfare as well as AI's redesign of future workforces) to those more lighthearted (H.R.'s service nickname, the artist behind John's wall hangings, and how the fellows would ride out a future pandemic). Finally, on the eve of America's Thanksgiving holiday, the fellows count their blessings – especially “Papa” Ferguson, who recently joined John (aka, “Blah-Blah” to his grandchildren) and H.R. (likewise, his grandkids' “Papa”) as a first-time grandfather. Subscribe to GoodFellows for clarity on today's biggest social, economic, and geostrategic shifts — only on GoodFellows.

German surfers are not stoked after one of the world's largest inland waves, in a river in Munich, disappeared following a city dredging project. Now the community is uniting to bring it back. Our correspondent investigates.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Amorim is running the club into new lows but no pressure from fans.. why..Champions League back up & running.. Chelsea with huge win over Barcelona.. but I wasn't surprised..Arsenal need to prove they are one of the big boys against Munich..Support the show

Send us a textIn this special edition of the FuturePrint Podcast, co-founders Marcus Timson and Frazer Chesterman sit down together to discuss the launch of FuturePrint Industrial Print, taking place 21–22 January 2026 at Motorworld Munich.Drawing on more than 20 years working together across major industry events - from FESPA to the original InPrint show - Marcus and Frazer explore why now is the right moment to launch a new event specifically focused on industrial manufacturing.They discuss how the industrial print landscape has evolved dramatically since the early 2010s. What was once an exploratory space is now home to mature, high-value applications in automotive, EV batteries, white goods, coatings, packaging, décor and additive manufacturing. Innovations in chemistry, ultra-high-viscosity fluids, functional deposition and AI-driven digital factories are creating new opportunities for manufacturers - and new demands for collaboration.This episode dives into the core concept behind the Munich event:A tightly curated group of around 50 exhibitorsA Lab environment with more than 15 live machinery demonstrationsA hybrid format combining exhibition, technical talks, and real-world application showcasesFour content streams covering Packaging & Labels, Functional & Additive, Décor, and AI for Industrial PrintA venue designed for accessibility, intensity, and high-value networkingFrazer and Marcus explain how the event model differs significantly from traditional print exhibitions: smaller, more targeted, easier to navigate, and carefully designed to maximise meaningful conversations between integrators, chemists, machine builders, manufacturers and OEMs.If you want to understand where industrial print is heading - and why the manufacturing landscape is embracing inkjet and digital deposition faster than ever - this episode is essential listening.Register for the event at futureprint.events and if you would like to join as our special podcast listener, use this code, FPBLACKFRIDAYListen on:Apple PodcastGoogle PodcastSpotifyWhat is FuturePrint? FuturePrint is a digital and in person platform and community dedicated to future print technology. Over 20,000 people per month read our articles, listen to our podcasts, view our TV features, click on our e-newsletters and attend our in-person and virtual events. We hope to see you at one of our future in-person events:FuturePrint TECH: Industrial Print: 21-22 January '26, Munich, Germany

Send us a textIn this special FuturePrint Podcast, Frazer is joined by three industry leaders who are teaming up to deliver a live 3D material jetting demonstrator at FuturePrint Industrial Print, Motorworld Munich (21–22 January 2026):Els Mannekens, Senior Formulation Chemist, ChemstreamJasmine Geerinckx, Co-Owner, IACSHolly Steedman, Business & Technology Development Director, IST INTECHTogether they unpack:Why partnerships matter: why no single supplier can deliver truly industrial inkjet alone, and how combining chemistry, print systems and curing unlocks robust solutions.What the Munich demonstrator will do: a compact 3D material jetting setup using a recirculating RICOH printhead, IACS InkDoc ink supplies, Chemstream's object and water-soluble support inks, and IST INTECH's UV LED curing – all running live on the show floor.Inside the chemistry: how ink formulation in 3D defines colour, mechanical strength, shrinkage, biocompatibility and even controlled release – and why multi-material printing demands carefully matched inks.The critical role of curing: Holly explains why curing strategy is often underestimated, how layer-by-layer UV LED control manages shrinkage and stress, and what happens when you get it wrong.Keeping the head healthy: Jasmine outlines how recirculating ink supply, stable pressure and temperature, and smart control interfaces keep industrial heads running reliably with minimal downtime.From 3D to 4D: Els shares emerging applications such as self-healing bandages and adaptive ergonomic tools, plus Holly highlights very real, right-now examples like printed dentures that address skills shortages and ageing populations.If you're interested in material jetting, 3D/4D printing, industrial inkjet integration or cross-vendor collaboration, this episode offers a clear, practical look at what's possible – and a preview of what you'll see live in Munich.Listen on:Apple PodcastGoogle PodcastSpotifyWhat is FuturePrint? FuturePrint is a digital and in person platform and community dedicated to future print technology. Over 20,000 people per month read our articles, listen to our podcasts, view our TV features, click on our e-newsletters and attend our in-person and virtual events. We hope to see you at one of our future in-person events:FuturePrint TECH: Industrial Print: 21-22 January '26, Munich, Germany

Episode 2 of our new podcast series on Collaborative Procurement and Contracting with Tom Douglas, Partner, Eversheds Sutherland and Edd Burton, Head of Advisory Services at AECOM. We welcome Dr Steffen Jung from Eversheds Sutherland's office in Munich where he heads the construction practice group. Together, they share their insights from Germany and the UK, on new methods of contracting, including collaborative procurement.

Forest play historic European rival from Sweden in Malmo on Thursday! ⚽Football Prizes⚽ Massive 2999 Instant Win Prizes!: https://footballprizes.co.uk/product/yates-2/ The European journey continues! This Thursday, Nottingham Forest welcomes Swedish giants Malmö FF to the City Ground for a crucial Europa League clash. This is more than just a group stage fixture; it's a meeting steeped in history, harking back to that unforgettable 1979 European Cup Final in Munich! Join Wolfie as he guides you through everything you need to know ahead of this intriguing European encounter. The biggest question facing Sean Dyche after the incredible 3-0 victory over Liverpool is selection! With a congested fixture list, who will get rested, and who will start to maintain momentum? Wolfie runs through the potential starting lineup, debating whether key players should be wrapped in cotton wool or if Dyche will stick with a winning formula for this important European tie. We analyse the balance between progression in Europe and freshness for the Premier League, discussing who might get their chance to shine on the European stage. Facing Malmö FF, the dominant force in Swedish football, will be a stern test of our tactical discipline. We break down Malmö's style and discuss how Forest can exploit their high defensive line. We want your input! Jump in the comments and let us know your preferred starting XI for Thursday night! Does history favour the Reds, or will Malmö spoil the party? Like, share, and subscribe to Forest Fan TV for all the best build-up! #nffc #europaleague #nottinghamforest Learn more about your ad choices. Visit podcastchoices.com/adchoices

The Psychgeist of Pop Culture: The Last of Us (Playstory Press, 2025) explores the psychological themes at the heart of The Last of Us franchise. Authors from media, culture, and fandom studies explore how trauma, grief, morality, survival, and revenge shape the story's characters and influence their choices. This book examines these themes across both video games (The Last of Us and The Last of Us 2) and HBO television adaptation, focusing on their unique approaches to telling the same emotionally resonant stories. This includes close readings of key characters - such as Ellie and Joel - and considers how their experiences reflect broader human struggles. Rudolf Thomas Inderst (*1978) enjoys video games since 1985. He received a master's degree in political science, American cultural studies as well as contemporary and recent history from Ludwig-Maximilians-University, Munich and holds two PhDs in game studies (LMU & University of Passau). Currently, he's teaching as a professor for game design and game studies at the University of Applied Sciences Neu-Ulm, has submitted his third dissertation at the University of Vechta, holds the position as lead editor at the online journal TITEL kulturmagazin for the game section, hosts the German local radio show Replay Value and is editor of the weekly game research newsletter DiGRA D-A-CH Game Studies Watchlist. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

The Psychgeist of Pop Culture: The Last of Us (Playstory Press, 2025) explores the psychological themes at the heart of The Last of Us franchise. Authors from media, culture, and fandom studies explore how trauma, grief, morality, survival, and revenge shape the story's characters and influence their choices. This book examines these themes across both video games (The Last of Us and The Last of Us 2) and HBO television adaptation, focusing on their unique approaches to telling the same emotionally resonant stories. This includes close readings of key characters - such as Ellie and Joel - and considers how their experiences reflect broader human struggles. Rudolf Thomas Inderst (*1978) enjoys video games since 1985. He received a master's degree in political science, American cultural studies as well as contemporary and recent history from Ludwig-Maximilians-University, Munich and holds two PhDs in game studies (LMU & University of Passau). Currently, he's teaching as a professor for game design and game studies at the University of Applied Sciences Neu-Ulm, has submitted his third dissertation at the University of Vechta, holds the position as lead editor at the online journal TITEL kulturmagazin for the game section, hosts the German local radio show Replay Value and is editor of the weekly game research newsletter DiGRA D-A-CH Game Studies Watchlist. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/popular-culture

Aujourd'hui dans Silicon Carne, on plonge dans le nerf de la guerre technologique :

Una de las mayores sorpresas en el campo de la Cosmología fue descubrir que el universo se estaba expandiendo y que la velocidad de expansión es mucho mayor cuanto más lejos estén las galaxias unas de otras. Esa velocidad se mide mediante la constante de Hubble. Pero hay un problema: Su valor no coincide según el método empleado, lo que se conoce como "Tensión de Hubble". Y esa constante es la que se emplea, entre otras cosas, para determinar la edad del universo. Un proyecto internacional se encargará de solucionar esa discrepancia en los valores. Si el problema estuviera en el modelo cosmológico estaríamos ante uno de los descubrimientos más significativos de este siglo. Hemos hablado con Licia Verde, investigadora ICREA del Instituto de Ciencias del Cosmos de la Universidad de Barcelona y coordinadora de RedH0T. -Con Fernando de Castro hemos comentado el proyecto NextBrain, un atlas del cerebro desarrollado por un equipo internacional con participación española, que pone a disposición de los médicos mapas de zonas concretas de este órgano, con posibles aplicaciones para el diagnóstico de enfermedades o de los efectos de un tratamiento. Bernardo Herradón nos ha hablado de las aplicaciones del flúor en medicina, del famoso teflón y de la mala prensa de este elemento químico por su papel en el agujero en la capa de ozono. María González Dionis nos ha contado un estudio sobre la evolución de los perros. Estos animales ya mostraban una gran diversidad hace 11.000 años. Hemos informado de la concesión de la Medalla a la Excelencia Científica 2025 al físico Juan Ignacio Cirac, director del Instituto Max Planck de Óptica Cuántica en Garching (Alemania) y profesor honorario de la Universidad Técnica de Munich. El jurado ha destacado la trascendencia científica de sus contribuciones en el ámbito de las Ciencias y Tecnologías Cuánticas. Y hemos rendido nuestro pequeño homenaje al matemático y divulgador Claudi Alsina, fallecido el pasado domingo a los 73 años de edad. Del medio centenar de libros que publicó y los más de 400 artículos que firmó, la mitad los dedicó a la educación de las matemáticas. El último libro lleva por título "El tercer lunes de enero es el día más triste del año. Matemáticas y Fake News", recientemente publicado por la editorial Ariel. Escuchar audio

0:00 - In the same weekend, Conner watched two films directed by Steven Spielberg about crimes against the Jewish people. Not intentional. But Conner saw “Munich” and “Schindler's List” for the first time and had feelings about both as they relate to recent world events. 8:00 - We stumble into a conversation about PureFlix, CleanFlix, VidAngel, all the “clean edited” film services.17:00 - LIGHT RECOMMENDATION - “Jurassic World: Rebirth” (2025). Spoiler-free.-----Executive Producers: Conner Dempsey • Dustin WeldonTheme Music by Dustin WeldonProduced & Engineered by Conner DempseyPowered by Zoom, QuickTime, Adobe Audition, & Adobe Premiere ProSpecial Thanks to Anchor FM (or “Spotify for Podcasters”, whatever)FOR ENTERTAINMENT PURPOSES ONLY. This is critique, protected under Fair Use.I DO NOT OWN THIS CONTENT. CONTENT IS IN THE PUBLIC DOMAIN.Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational or personal use tips the balance in favor of fair use.

Sometimes movies make cameos in other movies, that's what we are discussing with our double feature this week, 'The Man Who Shot Liberty Valance' and 'Munich.' Full spoilers ahead! The Man Who Shot Liberty Valance discussion starts 1:17, Munich discussion starts 29:26, Next episode recommendation starts 57:48

THE TEN MINUTE FORTNIGHT: Andy admires a test debutant towards the end of his fourth decade, and Toby encounters Plum Warner in a new context "I don't score quickly enough, that's my real issue." FROM THE ARCHIVES (10'00): The One-Eyed Cricketer - the remarkable life of Colin Milburn "Often you saw him batting with both feet off the ground, in a sort of gravity-defying act"  THE REVIEW (22'17): Basingstoke Boy by John Arlott (1990) "There's an extraordinary page where he describes narrowly missing joining the Manchester United team who were in the Munich air crash." Recorded 17 November 2025

Recorded live from the Cboe RMC floor in Munich, Cem Karsan sits down with volatility veteran David Dredge for a deep exploration of what truly drives risk. From the crash of 1987 to today's era of correlation, Dredge reframes volatility not as fear, but freedom. Through his F1 “brakes” analogy, he reveals why protection enables performance, and how convexity builds resilience in an uncertain world. Together, they trace the arc from structured-product flows to demographics, fiscal repression, and the coming global “Hunger Games” for savings. A masterclass in compounding through uncertainty.-----50 YEARS OF TREND FOLLOWING BOOK AND BEHIND-THE-SCENES VIDEO FOR ACCREDITED INVESTORS - CLICK HERE-----Follow Niels on Twitter, LinkedIn, YouTube or via the TTU website.IT's TRUE ? – most CIO's read 50+ books each year – get your FREE copy of the Ultimate Guide to the Best Investment Books ever written here.And you can get a free copy of my latest book “Ten Reasons to Add Trend Following to Your Portfolio” here.Learn more about the Trend Barometer here.Send your questions to info@toptradersunplugged.comAnd please share this episode with a like-minded friend and leave an honest Rating & Review on iTunes or Spotify so more people can discover the podcast.Follow Cem on Twitter.Follow David on X.Episode TimeStamps: 00:01:29 – Cem introduces David Dredge live from Munich.00:03:28 – Dredge recalls arriving in Asia before the 1987 crash.00:05:06 – The F1 brakes analogy—why protection enables speed.00:07:45 – The “preserve and enhance” portfolio that defied 65/35.00:10:57 – Rethinking 60/40 and the illusion of diversification.00:14:33 – Cem on $500 trillion of correlated assets.00:17:22 – Why covered calls lose to convexity over time.00:19:14 – Misreading 2022: correlation, not equities, was the risk.00:21:20 – When diversification fails, only convexity endures.00:27:13 – Value investing in volatility—buying what others suppress.00:37:48 – Euro...

In this monthly conversation series Grant Scott speaks with art director, lecturer and creative director Fiona Hayes. In an informal conversation each month Grant and Fiona comment on the photographic environment as they see it through the exhibitions, magazines, talks and events that Fiona has seen over the previous weeks. Mentioned in this episode: https://thephotographersgallery.org.uk/whats-on/boris-mikhailov-ukrainian-diary www.npg.org.uk/whatson/exhibitions/2025/cecil-beaton/ https://www.youtube.com/watch?v=rLjkQyp2Bjk www.saatchigallery.com/exhibition/futurespective Fiona Hayes Fiona Hayes is an art director, designer, consultant and lecturer with over 30 years' experience in publishing, fashion and the art world. She has been a magazine art director ten times: on Punch, Company, Eve, the British and Russian editions of Cosmopolitan, House & Garden,GQ India (based in Mumbai), MyselfGermany (in Munich), and Russian Vogue (twice). Between 2013 and 2019, as Art Director of New Markets and Brand Development for Condé Nast International, based in London and Paris, she oversaw all the company's launches – 14 magazines, including seven editions of Vogue. She still consults as Design Director at Large for Vogue Hong Kong. In 2002 she founded independent photography magazine DayFour, publishing it continuously until 2012. She is Co-Author and Art Director of The Fashion Yearbook, and creative director of books for South African media consultancy Legacy Creates. Outside the publishing world, she has been Art Director of contemporary art auction house Phillips de Pury in London and New York, and Consultant Art Director of Russian luxury retail group Mercury/TSUM. (Fiona would like to point out she is not Russian: she is proudly Irish and studied Visual Communication and History of Art and Design at NCAD Dublin.) She currently divides her time between design consultancy for commercial clients, and lecturing at Oxford Brookes University, the Condé Nast College of Fashion and Design, London, Nottingham Trent University, Ravensbourne University, and Leeds University. She lives in West London. @theartdictator Dr.Grant Scott After fifteen years art directing photography books and magazines such as Elle and Tatler, Scott began to work as a photographer for a number of advertising and editorial clients in 2000. Alongside his photographic career Scott has art directed numerous advertising campaigns, worked as a creative director at Sotheby's, art directed foto8magazine, founded his own photographic gallery, edited Professional Photographer magazine and launched his own title for photographers and filmmakers Hungry Eye. He founded the United Nations of Photography in 2012, and is now a Senior Lecturer and Subject Co-ordinator: Photography at Oxford Brookes University, Oxford, and a BBC Radio contributor. Scott is the author of Professional Photography: The New Global Landscape Explained (Routledge 2014), The Essential Student Guide to Professional Photography (Routledge 2015), New Ways of Seeing: The Democratic Language of Photography (Routledge 2019), and What Does Photography Mean To You? (Bluecoat Press 2020). His photography has been published in At Home With The Makers of Style (Thames & Hudson 2006) and Crash Happy: A Night at The Bangers (Cafe Royal Books 2012). His film Do Not Bend: The Photographic Life of Bill Jay was premiered in 2018. Scott's next book is Inside Vogue House: One building, seven magazines, sixty years of stories, Orphans Publishing, is on sale now wherever you buy your books. ©Grant Scott 2025

A billion-euro bet on Europe's most uncertain frontiers: climate, deep tech, and industrial transformation. Can government-backed funds catalyze global champions—or do they risk crowding out private capital?Dr. Elisabeth Schrey leads the Deep Tech & Climate Fonds (DTCF), a €1B investment vehicle co-financed by Germany's Future Fund and ERP Special Fund. From Munich to Berlin to Brussels, she's navigating the hardest question in European venture: how to deploy government capital without distorting markets.Together, we explore how DTCF is shaping Europe's growth-stage landscape, what it takes to invest in policy-fragile verticals like hydrogen and climate tech, and why Europe's future industrial champions may depend on funds like this.Here's what's covered:01:47 Why Elisabeth Took the Helm at DTCF (and What Gap It Fills)03:32 The Co-Investment Model: Benefits, Limits, and Founder Experience05:38 Crowding Out or Catalyzing? Steelmanning the Public Capital Debate07:21 When DTCF Steps Aside—and When It Competes for Deals09:54 Walking the Tightrope: Returns, Ecosystem Support, and Incentives14:36 Thinking Ahead: Could DTCF's Next Fund Be Purely Financial?15:42 The Scale Up Europe Fund vs. DTCF: Complement or Competition?17:18 Investing in Policy-Fragile Sectors Without Betting on Subsidies20:38 Defining “Readiness to Scale” in Uncertain Markets22:28 Avoiding the Subsidy Trap: Building Models That Work Without Support25:03 Climate & Hydrogen: Placing Bets Before the Hype27:36 Tech Waiting for the Market vs. Market Waiting for Tech29:06 Expanding the Portfolio: Semiconductors, Robotics, Cybersecurity31:27 Munich vs. Berlin: Why Munich Has Emerged as a Hardware Hub32:53 Corporates in Venture: Buffer, Booster, or Bottleneck?34:38 What Founders Need: Senior Hires & Serious Cashflow Models36:04 What Investors Get: Policy Links, Due Diligence, Deep Tech Edge38:22 Advice for Emerging VCs & Policymakers: Where the Next Gap Lies

Radio International - The Ultimate Eurovision Experience is broadcast from Malta's Radio 105FM on Tuesday evenings from 2100 - 0059 hours CET. The show is broadcast live on Wednesday evenings from 1900 - 2300 hours CET on the Eurovision Radio International Mixcloud Channel as well as on the Facebook Page of Eurovision Radio International with an interactive chatroom.         AT A GLANCE - ON THE SHOW THIS WEEK  The Eurovision Song Contest 2026 National Final Season Tribute to the Kessler Twins (Germany 1959)  The Junior Eurovision Song Contest 2025 - Review and Preview Eurovision Spotlight: Austria's History at the Eurovision Song Contest  with Ross Bennett Eurovision News with Nick van Lith from www.escXtra.com Eurovision Birthday File with David Mann Eurovision Cover Spot with David Mann Eurovision Calendar with Javier Leal  National Final Update for Junior and Eurovision Song Contest with Alain Forotti  New Music Releases by Eurovision Artists  Your music requests    Alice and Ellen Kessler (Germany 1959)  at OGAE Germany Convention 2015 Tribute to The Kessler Twins (Germany 1959): The Eurovision Community received sad news on the passing away of Alice and Ellen Kessler also known as the Kessler Sisters or the Kessler Twins, at the age of 89 in Munich, Germany on 17 Nov 2025. The Kessler Twins represented Germany at the Eurovision Song Contest 1959 with the song "Heute abend wollen wir tanzen gehen" which came 9th. As a tribute, Radio International will rebroadcast the interview that JP and Eric did with the twins at the OGAE Germany Convention in January 2015 in Munich.  The Junior Eurovision Song Contest 2025: The 23rd edition of the Junior Eurovision Song Contest will be held on Saturday 13 Dec 2025 from the Olympic Palace in Tblisi in Georgia with young artists from 18 countries taking part. In the running order: Malta, Azerbaijan, Croatia, San Marino, Armenia, Ukraine, Ireland, The Netherlands, Poland, North Macedonia, Montenegro, Italy, Portugal, Spain, Georgia, Cyprus, France and Albania.  Returning countries are Azerbaijan, Croatia and Montenegro while Estonia and Germany are taking a break. The Hosts of the show are David Aladashvili and Liza Tsiklauri. The show starts at 1700 hours CET. Last year's Winner was Georgia's Andria Putkaradze who won with the song "To my mom".  Radio International will be introducing the songs to the listeners over the next weeks until the week on the Junior Eurovision Song Contest 2025. But also there will some highlights from past editions of the Junior Eurovision Song Contest.    The Home Composed Song Contest 2025 - The Grand Final Results Show on 29 Nov 2025: The annual music competition for non-professional musicians takes place again and is already in full swing. The public and jury have the opportunity to cast their votes as well. Visit the website of the Home Composed Song Contest 2025 - click here The Home Composed Song Contest is in its 34th year, this is a competition for Eurovision fans who write, perform and produce their own music, who enter their own original song composition (audio only) and then also take part as a jury, to help choose the winning song. This year there are 24 songs from 12 different countries, and you can listen to the songs, and read the lyrics and bios on the official website - click here The Radio International Team once again forms one Jury and you will be able to hear the songs also on thre next three edition sof Radio International. Well done to all participants and may the best entry win. Last week Radio International introduced the first eight of the 24 songs of the Home Composed Song Contest 2025. This week listen to the third and final segment of eight songs from the contest. The results will be published on 29 Nov 2025 during the Grand Final Show on the contests YouTube Channel. Click here to watch the Grand Final. The time of the show will be communicated here nearer the date.         The Eurovision Spotlight - The history of Austria at the Eurovision Song Contest:  It is Autumn 2025 it also time for the traditional look at the next host country's Eurovision Song Contest entries. JJ won Eurovision 2025 and with that Austria will host the Eurovision Song Contest 2026 in the Wiener Stadthalle on 12 and 14 May 2026 for the two Semi Finals and the Grand Finale to take place on Saturday, 16 May 2026. Over the next weeks and before the National Final Season for 2026, Radio International's team members will be reviewing all the Eurovision entries from Austria. Ross Bennett will be continuing series of the Eurovision Spotlight looking at the history of Austria at the Eurovision Song Contest.   Eurovision News, New Song Releases, Birthday File, Coverspot, Eurovision Calendar:Also JP will be joined by David Mann for the Eurovision Birthday File and Eurovision Coverspot.  Javier stands in for Nick and will be presenting the Eurovision News courtesy of escXtra.com. There will be a lot of the great new releases of Eurovision artists on the show as well as great Eurovision Classics. Javier will be updating us on the upcoming Eurovision events in the Eurovision Calendar and Alain Forotti gives us already some updates of the National Finals regarding the Junior Eurovision Song Contest 2025 and the Eurovision Song Contest 2026 and and....   For full details of this week's Show Content and Play List - click here

In the summer of 2015, there was a surge in the number of people from Syria, Afghanistan and Iraq, seeking asylum in Europe. Social Democrat politician Aydan Özoğuz was Angela Merkel's minister of state concerned with immigration, refugees and integration from 2013 to 2018. She describes to Josephine McDermott visiting her father's home city of Kilis in Turkey, near the Syrian border in 2015, where refugees were being sheltered. And she recalls the motivation for Mrs Merkel's decision to suspend the EU's Dublin Regulation which temporarily allowed free passage for Syrian asylum seekers, but drew opposition from critics. Eye-witness accounts brought to life by archive. Witness History is for those fascinated by the past. We take you to the events that have shaped our world through the eyes of the people who were there. For nine minutes every day, we take you back in time and all over the world, to examine wars, coups, scientific discoveries, cultural moments and much more. Recent episodes explore everything from the death of Adolf Hitler, the first spacewalk and the making of the movie Jaws, to celebrity tortoise Lonesome George, the Kobe earthquake and the invention of superglue. We look at the lives of some of the most famous leaders, artists, scientists and personalities in history, including: Eva Peron – Argentina's Evita; President Ronald Reagan and his famous ‘tear down this wall' speech; Thomas Keneally on why he wrote Schindler's List; and Jacques Derrida, France's ‘rock star' philosopher. You can learn all about fascinating and surprising stories, such as the civil rights swimming protest; the disastrous D-Day rehearsal; and the death of one of the world's oldest languages.(Photo: A migrant from Syria holds a picture of Angela Merkel as he arrives at a railway station in Munich. Credit: Sean Gallup/Getty Images)

We ride around Munich from the city center to the suburban palaces. We hit it all, trams, buses, U-Bahn and S-Bahn. Home of BMW, our trip reveals a car capital where transit is still king. • Major renovations and expansion of the Munich Hauptbahnhof and what it changes• tram frequency, speed differences versus Vienna, and signage wins• walkability around Marienplatz and Viktualienmarkt• cross-town bus to BMW and Olympic Park to test outer links• U-Bahn service levels, proof-of-payment, and crowd management• S-Bahn scale today and why a new tunnel under construction matters• Munich's centralized rail versus Vienna's stronger orbitalsIf you are not already subscribed to the channel, we'll have the final part of this European trip from Zurich coming up in just a few weeks. So, subscribe to hear the latest!If you want to support the show directly, you can also do so via our PatreonSend us a textSupport the show

Episodio número 35 de Cuéntame Más Ciencia con Ana Mora Boza, doctora en Ingeniería y Ciencias de Materiales, quien se haya iniciando su propia investigación en Munich, tras haber pasado por el Georgia Institute of Technology.En esta conversación, Ana nos comparte su trayectoria desde sus inicios en la biotecnología hasta su actual trabajo en ingeniería de materiales. Habla sobre su curiosidad científica desde pequeña, la falta de referentes académicos en su familia, y cómo ha navegado por la competitividad en la academia consiguiendo numerosas becas y oportunidades.Ana también destaca la importancia de los mentores en su carrera y su interés por la microfluídica, que la llevó a trabajar en los órganos en chip. Un concepto revolucionario que está en pleno auge. ¿Seremos capaces de generar órganos completos en un laboratorio?Episodio grabado por ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Fernando de Miguel⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Cuéntame Más Ciencia es un podcast financiado por la Fundación Ramón Areces y elaborado por el programa E-Visibility de la Comisión de Comunicación de ECUSA. Visita nuestra web ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.ecusa.es⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ y síguenos en las redes sociales⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Las opiniones y declaraciones expresadas en Cuéntame Más Ciencia representan el punto de vista de cada participante y no de ECUSA como asociación, ni de cualquier otra institución.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. It's world diabetes day! It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922.   WDD was created in 1991 by International Diabetes Federation (IDF) and the World Health Organization and became an official United Nations Day in 2006 with the passage of United Nations Resolution 61/225. There will be a ton of stuff in your feeds today and that's great! I'm going to keep this to a pretty normal in the news episode.. although I do have my own World Diabetes Day announcement – I want YOUR community commercials. You could have an ad for your event or your blog or your project right here! There's a post on the website explaining it all and I'll come back at the end of the episode and tell you more. XX The Primary Oral Insulin Trial (POInT) is the first large-scale clinical trial to test whether giving at-risk children daily oral insulin could prevent or delay type 1 diabetes (T1D). Conducted by researchers from Helmholtz Munich and the Technical University of Munich across five European countries, the study enrolled more than 1,000 children with a genetic risk for T1D. Results published in The Lancet show that while oral insulin did not prevent the development of islet autoantibodies—an early sign of diabetes—it was safe and well tolerated. Importantly, researchers found that some children who received oral insulin developed diabetes more slowly than those given a placebo, suggesting potential protective effects in certain genetic subgroups.   Further analysis revealed that the response to treatment depended on the child's insulin gene variant. Children with genetic versions that raise diabetes risk appeared to benefit, showing delayed onset of the disease, while those without the risk variant did not. These findings point toward a future of personalized prevention, where genetic screening could help identify which children might benefit most from oral insulin. Researchers will continue following the participants until age 12 to assess long-term effects. The study marks a major milestone in decades of diabetes prevention research, highlighting both the promise and complexity of developing tailored, early interventions against type 1 diabetes. XX Joint US-Chinese research looking at generating new beta cells from stomach cells. Upon turning on the "genetic switch," the human stomach cells were converted to insulin-secreting cells within the mice and resembled pancreatic beta cells with respect to gene and protein expression. Encouragingly, when those experiments were done with diabetic mice, insulin secreted from the transformed human cells helped control blood sugar levels and ameliorated diabetes. The scientists hope that a similar approach can be taken to convert cells from a patient's own stomach into insulin-secreting cells directly within the body. Importantly, additional studies are needed to address if this approach is safe and effective to be used in patients. https://www.technologynetworks.com/cell-science/news/human-stomach-cells-tweaked-to-make-insulin-406694 XX A new study in Nature Metabolism may help explain why children born to mothers with type 1 diabetes are less likely to develop the disease early in life compared to those whose fathers or siblings have it. Researchers looked at nearly 2,000 mothers and their children and found that  kids whose moms have type 1 diabetes show changes in their DNA that may actually help protect them. These aren't genetic mutations, but epigenetic changes — chemical tags that turn certain genes on or off. The study found these changes in genes tied to the immune system and type 1 diabetes risk, suggesting that a mother's condition during pregnancy can shape her child's immune response in a protective way. Scientists identified more than 500 areas of DNA where these changes occurred, many in regions that control how the body's immune system works. Most of the changes appeared to calm down the kind of overactive immune response that leads to type 1 diabetes. Researchers even created a "methylation score" to help measure this protective effect. They say the next step is to confirm these results in more diverse groups and figure out exactly how these DNA changes help prevent early diabetes. https://www.news-medical.net/news/20251110/Maternal-type-1-diabetes-may-protect-children-from-developing-the-disease.aspx XX A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may develop early vascular dysfunction—independently of metabolic health. The finding may help shape future strategies to prevent cardiovascular disease early in life.     Children of women with type 1 diabetes are known to be at increased risk of developing cardiovascular diseases. This new study, published in Cell Reports Medicine, is the first to show that the risk is linked to early dysfunction in blood vessel cells in sons, even before any metabolic issues arise. The team is now investigating the long-term effects of maternal diabetes, with a particular focus on why sons seem to be affected earlier than daughters. https://medicalxpress.com/news/2025-11-sons-mothers-diabetes-early-vascular.html XX A new study presented at Kidney Week 2025 has shown that the drug finn-uh-near-own  a nonsteroidal mineralocorticoid-receptor antagonist, significantly reduced albuminuria—a key marker of kidney damage—in people with type 1 diabetes (T1D) and chronic kidney disease (CKD). This is the first major breakthrough for this population in more than 30 years. Researchers found that patients taking finerenone saw a 25% average reduction in albuminuria compared to placebo, an improvement that suggests a lower long-term risk for dialysis or kidney transplant. The phase 3 FINE-ONE trial involved 242 adults with T1D and CKD, and results showed benefits as early as three months. The drug was generally well tolerated, with side effects similar to those seen in patients with type 2 diabetes, though mild hyperkalemia (high potassium levels) was slightly more common. Experts say the findings could change the way doctors treat kidney complications in type 1 diabetes, an area that hasn't seen new therapies since the early 1990s. Currently, treatment options rely on blood pressure and blood sugar management, along with renin-angiotensin system (RAS) inhibitors. Finerenone, which is already approved for type 2 diabetes-related CKD, targets overactivation of a receptor that drives kidney damage. Based on these results, Bayer plans to seek FDA approval in 2026 for use in people with T1D and CKD. Researchers and clinicians alike are calling the study "groundbreaking," noting that it opens the door to future research on how finerenone might not just slow kidney decline—but possibly prevent it altogether. https://www.medscape.com/viewarticle/finerenone-offers-hope-kidney-disease-type-1-diabetes-2025a1000uzi?form=login   XX This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world's smallest, durable automated insulin delivery system — to more users. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software.   Tandem — one of the largest diabetes tech companies in the world — expects to begin a limited rollout next month, followed by full commercial availability in early 2026. This marks the latest milestone for the company, which continues to expand its offerings and widen its reach within the diabetes patient population.   We had a great interview with Tandem on our previous episode, but as I said at the time, it was coming before their earnings call. So here's an update: The company plans to submit the tubeless mobi to the fda before the end of this year.. possible approval and shipping date is hoped for by middle of 2026. Trials for their fully closed loop next-generation algorithm which we tlkaed abou ton the show should be launched in 2026 The Sigi patch pump will be developed and launched as a next-generation version of the Mobi Great job by Dr. David ? Ahn – he posted on IG after getting a message from tandem CEO John Sheridan? 1. First, the Tandem X3 *is* still absolutely in development, contrary to my speculation In yesterday's video. As many of you appropriately pointed out, there is definitely a market for a 300 unit pump, a pump with a screen, and a pump that does not require smartphone control. So from our brief chat, the sense I got that is that the X3 would be more of a refresh of the X2 with newer components, such as a USB-C connector and better memory, rather than a total redesign from the ground up. In terms of timing, all I could get was that it was "not too far distant in the future," which could mean anything I guess, but at least it's still on the way! 2. Next up, he also reassured me that they are working closely with Dexcom to support the G7 15 Day sensor within the next few months. I suspected as much, but it's always good to hear confirmation. 3. Lastly, he did confirm that Tandem is far along in developing a Caregiver/Follow app to allow the remote viewing of glucose and insulin data from a Tandem pump. He explained that it will be based on Sugarmate, the popular diabetes data dashboard app that Tandem acquired back in Jun 2020. While I don't know if every feature will make it into the Tandem caregiver app, Sugarmate is well-liked for its highly customizable dashboard and highly configurable alerts. Sugarmate even has the option to send a text message or phone call for urgent lows. Regardless, a true follow/Caregiver app will be welcomed with open arms by all caregivers and Tandem users who use Libre 3 Plus. https://time.com/7318020/worlds-top-healthtech-companies-2025/ XX Senseonics submits Eversense 365 – their year long implantable CGM for a CE mark, European Approval and expect to launch there soon. Eversense will be integrated with the sequel twist pump – again I'm hearing soon but no timeline. Intersting to note that one year inseration was approved in the US just about a year ago, so the first patients will be having their CGMs changed out – for the first time – pretty soon. https://www.drugdeliverybusiness.com/senseonics-q2-2025-sales-beat-ce-mark/ XX A confusing study out of Rutgers - these researcher say  metformin reduces some of the key benefits normally gained from regular physical activity. These include improvements in blood vessel health, physical fitness, and the body's ability to regulate blood sugar. Since 2006, doctors have typically encouraged patients with elevated blood sugar levels to combine metformin with exercise, expecting that the two proven treatments would produce stronger results together. However, the new research suggests this may not be the case. In this study, Exercise alone improved vascular insulin sensitivity, meaning blood vessels responded better to insulin and allowed more blood flow to muscles. This matters because insulin's ability to open blood vessels helps shuttle glucose out of the bloodstream and into tissues, lowering blood sugar after meals. But when metformin was added, the improvements shrank. The drug also diminished gains in aerobic fitness and reduced the positive effects on inflammation and fasting glucose. The findings don't mean people should stop taking metformin or exercising, Malin said. Instead, it raises urgent questions for doctors about how the two treatments can be combined and the need for close monitoring. Malin hopes future research will uncover strategies that preserve the benefits of both. https://scitechdaily.com/popular-diabetes-drug-metformin-may-cancel-out-exercise-benefits-study-warns/ XX XX https://www.medtechdive.com/news/Revvity-Sanofi-diabetes-test-Kihealth-seed-round/802133/   XX Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or notifications related to estimated glucose values, according to a Food and Drug Administration database entry posted Oct. 30. The glucose sensor and the app are still available, but Dexcom required users to update the app to a new version. Dexcom began the recall on Aug. 28. The FDA designated the event as a Class 1 recall, the most serious kind. Dexcom sent a notification to customers in September about the software bug, which applies to version 1.15 of the G6 Android app. To use the app, customers must update it to a new version, according to the entry. https://www.medtechdive.com/news/dexcom-recall-g6-cgm-app/804630/ XX https://www.medscape.com/viewarticle/automated-insulin-delivery-boosts-glycemic-control-youth-2025a1000ub3 XX Tidepool partners with smart ring maker OURA.. press release says: to support a groundbreaking dataset intended to be broadly available for diabetes research, with participation limited to individuals who opt in through Tidepool.         Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends, and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs) and insulin pumps. The result will provide researchers with an unprecedented dataset to accelerate the development of new clinical guidelines, next-generation diabetes technology, and personalized care models.   Recruitment is expected to launch in early 2026 through an IRB-approved study. By opting in to this study, participants consent to sharing their data with Tidepool's Big Data Donation Project, where data is de-identified and, with participant consent, shared with academics, researchers, and industry innovators to accelerate diabetes research. https://aijourn.com/tidepool-collaborates-with-oura-to-advance-inclusive-diabetes-research-through-wearables/ XX Eli Lilly launches two new clinical trials for baricitinib. These phase 3 trials will investigate whether the drug can delay T1D onset or progression and will open for recruitment soon. Baricitinib has the potential to extend the "honeymoon period" of T1D, meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications. JAK inhibitors, including baricitinib, are already FDA-approved for other autoimmune diseases, such as rheumatoid arthritis, alopecia, and more. JAK signaling pathways are associated with overactive immune responses, so blocking this pathway may turn down the immune response. The phase 2 Breakthrough T1D-funded BANDIT study was key in showing that this drug is safe and effective in T1D. Importantly, baricitinib is a once-daily oral pill—meaning its use is simple and easy.   https://www.breakthrought1d.org/news-and-updates/two-new-trials-baricitinib-to-delay-t1d/ XX   Insulet is taking diabetes awareness into the workplace. Having found 79% of people with diabetes have faced bias or misunderstanding at work, the medtech giant is rolling out a range of resources intended to trigger changes in how workplaces approach the condition. Lots going on for Diabetes Awareness month.. some notables.. Insulet's "The Day Diabetes Showed up to Work" campaign. based on a survey of almost 10,000 people 79% of people with diabetes have faced bias or misunderstanding at work,.   Almost 90% of people with diabetes surveyed reported experiencing barriers at work due to their condition, and more than 40% of people with diabetes and caregivers said they have workplace-related anxiety tied to the metabolic disease. Around one-quarter of respondents reported fears that diabetes could limit opportunities or lead to workplace discrimination and judgment, and a similar proportion of people said they conceal their condition. https://www.fiercepharma.com/marketing/widespread-workplace-challenges-people-diabetes-spark-insulet-campaign XX New directive issued by the Trump administration could mean people seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity.   The guidance, issued in a cable the State Department sent to embassy and consular officials and examined by KFF Health News, directs visa officers to deem applicants ineligible to enter the U.S. for several new reasons, including age or the likelihood they might rely on public benefits.   The guidance says that such people could become a "public charge" — a potential drain on U.S. resources — because of their health issues or age.   The cable's language appears at odds with the Foreign Affairs Manual, the State Department's own handbook, which says that visa officers cannot reject an application based on "what if" scenarios, Wheeler said.   The guidance directs visa officers to develop "their own thoughts about what could lead to some sort of medical emergency or sort of medical costs in the future," he said. "That's troubling because they're not medically trained, they have no experience in this area, and they shouldn't be making projections based on their own personal knowledge or bias."   Immigrants already undergo a medical exam by a physician who's been approved by a U.S. embassy. https://www.npr.org/2025/11/12/nx-s1-5606348/immigrants-visas-health-conditions-trump-guidance XX SAN DIEGO---Nov. 14, 2025—DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom's World Diabetes Day campaign. The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person's experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom's glucose biosensing technology. "Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals," said Maria Alejandra Jove Valerio, one of Dexcom's new advocates. "What began as a diagnosis at age seven has grown into a lifelong mission to uplift others." This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom's history of and commitment to giving real people with diabetes a platform to share their story on a global stage. Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate's personal experience with diabetes, what misconceptions about diabetes they'd like to dispel and how they want to inspire others with diabetes to discover what they're made of. To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo*Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day. Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes. "Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique an XX On what would have been the 100th birthday of its visionary founder Alfred E. Mann, MannKind Corporation (Nasdaq: MNKD), in partnership with Alfred E. Mann Charities and The Diabetes Link, announced the launch of the Centennial Al Mann Scholarship. The new program will distribute $100,000 in scholarship funds to support at least 10 young adult students living with diabetes as they pursue higher education in life sciences.   Launched in Diabetes Awareness Month, the scholarship program honors Alfred E. Mann's enduring legacy of innovation, philanthropy, and his lifelong commitment to improving the quality of human life through medical advancement. Deeply passionate about giving back, Mr. Mann believed that his success should continue to serve humanity long after his passing, a belief that lives on through this initiative.   Each scholarship recipient will be awarded up to $10,000, distributed in annual installments of $2,500 throughout the course of their studies. Depending on the length of their degree program, recipients may receive between two and four installments (up to the full $10,000 per student). The first awards will be made for the 2026 academic year.   "Al Mann dedicated his life to helping people with serious medical conditions live longer, healthier lives. This scholarship is a reflection of that spirit," said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. "By supporting students living with diabetes who are pursuing careers in the life sciences and adjacent fields, we're honoring Al's legacy and investing in the future of innovation and care. This program is about giving back to the community we serve and empowering the next generation to carry forward Al's mission of making a meaningful difference in people's lives."   Alfred E. Mann Charities and MannKind will partner with The Diabetes Link to launch the program to serve young adults (aged 18-22) living with either type 1 or type 2 diabetes with their higher education goals. Those eligible will include incoming freshmen and current students pursuing 2- or 4-year degrees. The application window will open in early 2026, and for those interested in receiving notifications, an early interest form is available. More information about the scholarship will be shared on thediabeteslink.org.   "We're honored to partner with MannKind to expand access to higher education for young adults with diabetes," said Manuel Hernández, Chief Executive Officer of The Diabetes Link. "At a time when the cost of college continues to rise, this scholarship helps ease the financial burden and carries forward the spirit of Al Mann, whose vision and legacy continue to inspire us."   Mr. Mann was MannKind's Chairman of the Board from 2001 until his passing in February 2016 and served as Chief Executive Officer from November 2003 until January 2015. Driven by a desire to improve lives and fill unmet medical needs, for more than six decades he founded 17 companies and developed breakthrough medical devices, including insulin pumps, cochlear implants, cardiac pacemakers and retinal prostheses. In 1997, Mr. Mann saw the potential of a dry powder insulin formulation to change the way diabetes is treated and invested nearly $1 billion to help bring Afrezza® (insulin human) Inhalation Powder to market.   About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.   With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.   Learn more at mannkindcorp.com.   About Alfred E. Mann Charities, Inc. Alfred E. Mann Charities, Inc. became active in 2016, following the passing of the organization's benefactor, Alfred E. Mann. Throughout his life, Al was passionate about philanthropy and was dedicated to prolonging and improving the quality of human lives through innovation in the fields of healthcare and the use of medical devices. It was important to Al that his success and assets continue to better human lives even after his own passing.   Alfred E. Mann Charities, Inc. (formerly known as Alfred E. Mann Family Foundation) has similarly placed its primary focus on healthcare and medical innovation, as our organization believes this is where we can have the greatest impact on humanity and human health throughout the world. Alfred E. Mann Charities, Inc. is also dedicated to promoting arts, culture, education, and community development across Los Angeles and throughout the world in order to best serve people and this planet.   Learn more at aemanncharities.org.   About The Diabetes Link The Diabetes Link is the only national nonprofit organization dedicated to empowering young adults living with diabetes. Founded by and for young adults, The Link serves this community through peer support, leadership opportunities, and practical, evidence-based resources designed for real life. Its network of campus and community chapters, active online community, and robust Resource Hub help young adults navigate the transitions of early adulthood while managing diabetes. The organization envisions a future where every young adult living with diabetes has

In this episode, host Maya sits down with Jakub Fedorowicz, Head of M&A at R.Power Renewables, to explore why Poland's battery storage market is ready for take-off. Recorded at the Energy Storage Summit – Europe in Munich, the conversation delves into R.Power's evolution from a solar developer to a multi-technology IPP, the country's shifting regulatory landscape, grid access challenges and the growing investor appetite for storage.Produced and edited by Leonard Müller.Interested in tickets for the awards show? Email conferences@inspiratia.com or buy them directly on our website.Reach out to us at: podcasts@inspiratia.comFind all of our latest news and analysis by subscribing to inspiratiaListen to all our episodes on Apple Podcasts, Spotify, and other providers. Music credit: NDA/Show You instrumental/Tribe of Noise©2025 inspiratia. All rights reserved.This content is protected by copyright. Please respect the author's rights and do not copy or reproduce it without permission.

Welcome back to the Sorry to Interrupt podcast! In a special 2-part Monday episode, Tom and Sean start off by reacting to the Giants firing Brian Daboll and discuss why now was the right time to make the move and also discuss what could be next for Big Blue. Next, they dive into the notable results from Sunday including a Bills disaster in Miami, another passed test for the Pats, a rebound for the Colts in Munich and who truly is the best team in the NFC? Then in Part 2, Sean is back to go deeper into detail on the situation surrounding the Giants by discussing how they got to this decision today, the downfall of Daboll, why Schoen is safe and who the best candidates are for the next HC for New York. Everyone enjoy the pod!

Text your thoughts and questions!It's far too easy to get caught up in a relentless cycle of stress and negative thinking in the world we live in. You want to feel calm, resilient, and finally break free from that stuck loop of worry, but where do you start? On this episode of the Positively LivingⓇ Podcast, I am joined by happiness coach Julie Leonard to discuss a path that leads to less overwhelm and a more intentionally happy life. Julie Leonard is a life coach, author, and self-proclaimed happiness evangelist based in Munich, Germany. After overcoming her own challenges with anxiety and a negative inner dialogue, Julie dedicated her career to understanding and sharing the science of happiness. With a background in psychology and experience in mental health, she specializes in helping women change limiting beliefs and negative thinking into positive action. Her mission is to share practical tools and knowledge to help people navigate life and live a more intentionally happy life, focusing on what is truly within their control.In this episode of the Positively LivingⓇ Podcast, Julie shares how happiness isn't just about avoiding struggle but about building the internal tools to handle what life throws at you. Our conversation provides you with actionable advice you can take today to cultivate resilience and live a more proactive, positive life. Julie and I cover the following topics:The difference between stress and distress. Identifying what true happiness looks like, separate from external validation or material gain.The societal and cultural messages that lead us to seek outward solutions for an inward problem.Practical strategies for taking back control and living a more intentional and happier life. You have more control over your happiness than you think. Now is the time to embrace that control and commit to building your own resilience toolkit. Learn more about Positively LivingⓇ and Lisa at https://positivelyproductive.com/podcast/Stop trying to fit into someone else's productivity rules! Grab my free Productivity Toolkit, a collection of workbooks designed to help you explore how you work, uncover what truly matters to you, and create your very own energy-friendly systems. Get it here: www.positivelyproductive.com/plpkitCONNECT WITH JULIE LEONARD:InstagramWebsiteCONNECT WITH LISA ZAWROTNY:FacebookInstagramResourcesWork with Lisa! LINKS MENTIONED IN THIS EPISODE:(Find links to books/gear on the Positively Productive Resources Page.)Ep 41 (Original Episode)Ep 197Self-Care Podcast PlaylistDance Song Playlist V1, V2, V3Music by Ian and Jeff Zawrotny

Twinkle lights, mulled wine, and cozy vibes! Genni from @travelingfranklins joins Kelsey to share everything you need to know about visiting Europe's Christmas Markets. In December 2024, she and her mom explored Berlin, Munich, Salzburg, and Paris at Christmastime. She shares their favorite markets, the best food and drink (glühwein, wurst, pretzels, Kasespatzle), souvenir tips, and what to wear to stay warm. Kelsey's Comfrt Hoodie 15% off discount link: https://comfrt.com/?growi=kelsey279This episode is now available to watch on YouTube: https://www.youtube.com/@kelseygravesIf you'd like to share about your trip on the podcast, email me at: kelsey@triptalespodcast.comBuy Me A Coffee: https://buymeacoffee.com/kelseygravesFollow me on Instagram: https://www.instagram.com/kelsey_gravesFollow me on TikTok: https://www.tiktok.com/@mskelseygravesJoin us in the Trip Tales Podcast Community Facebook Group: https://www.facebook.com/groups/1323687329158879Mentioned in this episode:- Genni's Podcast: https://podcasts.apple.com/us/podcast/lazy-budget-travel-tips/id1797989736- Christkindl Markets- KLM Airlines- AMSTERDAM: Canal Cruise, Hop On Hop Off Tour- BERLIN: Moxy Airport Hotel, Bolt for taxis, Ku'damm shopping district, Kaiser Wilhelm Memorial Church, H10 Hotel Berlin, Alexanderplatz Christmas Markets, Glühwein, Gendarmenmarkt, Christmas pyramids, Kasespatzle (German mac and cheese), Lebkuchen (German gingerbread cookies), Schmalzkuchen (German donuts)- MUNICH: Lufthansa Airlines, Munich Airport Christmas Market, Marienplatz Market, Mio by Amano Hotel, The Sendlinger Tor gate, traditional Bavarian restaurant: Der Pschorr, Medieval Christmas Market- SALZBURG: The Bavarian Pass, Old Town Salzburg, Sound of Music, Christmas Wonderland Bar + Lounge near St. Peter's Church- Pack bubble wrap- PARIS: Ladurée Paris at Christmas, The Palais-Royal, Hôtel Thérèse, Tuileries Garden, Galeries Lafayette, Christmas Illuminations Hop On Hop Off TourTrip Tales is a travel podcast sharing real vacation stories and trip itineraries for family travel, couples getaways, cruises, and all-inclusive resorts. Popular episodes feature destinations like Marco Island Florida, Costa Rica with kids, Disney Cruise Line, Disney Aulani in Hawaii, Beaches Turks & Caicos, Germany, Austria, Park City ski trips, Aruba, Italy, Ireland, Portugal's Azores, New York City, Alaska cruises, and U.S. National Parks. Listeners get real travel tips, itinerary recommendations, hotel reviews, restaurant recommendations, and inspiration for planning their next vacation, especially when traveling with kids.

In this Happy Pod special we're in Munich, Germany for One Young World. We speak to survivors of the atomic bombing of Nagasaki and their families as they turn their painful memories into a call for peace and the end of nuclear weapons. They're part of a group that won the Nobel Peace Prize in 2024. Also: The young Argentine harnessing Artifical Intelligence to spot wildfires; Zaynab Mohamed - the first Muslim woman elected to Minnesota's Senate at just 25; the 'TikTok Mayor' using social media to show life in charge of a tiny Spanish village; and the England football star, Georgia Stanway, who's using Euros success to change the game for the next generation of female players. Our weekly collection of inspiring, uplifting and happy news from around the world.Presenter: Holly Gibbs. Music composed by Iona Hampson

The Freedom of Surrender: Forty Devotions for a Joyful Life in ChristFind joy and freedom in surrenderLetting go is hard.To surrender is to let go of what we tightly grip, the good and the bad. It's a relinquishing of control, a recognition that God alone can meet our deepest needs. It's a holy pause that entrusts each hope, each worry, and each pressing concern to the One whose love for us is beyond measure. And in this surrender, we enter into freedom. But, even so, letting go often feels easier said than done.In The Freedom of Surrender, author Mary DeMuth invites you to journey through forty days of entrusting specific areas of your life to God―your inner struggles, your family, your expectations, your regrets, your ministry, your grief, your relationships, your job, your health, your finances, your future, and more. Every daily devotion includes Scripture, prayer, and Mary's original art that help you cast each care on the One who cares for you.On this forty-day journey, you'll learn:How to trust that God is in control, even in moments of chaos and stress.True joy and freedom can happen when we release what we're holding too tightly.God's plan is to see you thrive and grow.Prayer opens the door to freedom and peace.Even in your struggles, you are never alone.When we entrust our stresses and worries to God, we embrace the reality that's always been true: Our “control” is an illusion. God alone can meet our needs, heal our wounds, and guide our steps. From this place of total reliance on God, we can experience deep joy and the peace that passes understanding.What are you holding too tightly? Experience freedom as you invite Jesus to help you surrender all.Purchase a copy of Making Marriage Easier here.Connect with Mary DeMuthWebsite | Facebook | X | Instagram | YouTubeMary loves Jesus. And really that's the most important thing about her. It's not writing or speaking or praying or mommying or any other -ing you can find. She flat out loves Him. Why? Because he has utterly, truly, completely re-storied her. See her testimony below.She has three adult children, and she's been married to Patrick for 33 years now. Mary counts those relationships as the most important people in her life. In the mid 2000s, their family helped plant a church in Southern France–a difficult, but amazing experience. In her spare (ha!) time, she loves to cook, run, garden, decorate, paint, and do interior design. You can find all her artwork here.She's been writing for 30+ years–half of them in obscurity. She mentored many writers during that time, and continues to do so through the Rockwall Christian Writers Group and some of her  instructional books. Mary pioneered a literary agency in 2022, Mary DeMuth Literary, where she shepherds writers toward traditional publishing.She currently lives in North Texas, serves in her local church alongside her husband, and she's had the privilege of speaking around the world in places like Johannesburg, Monaco, Geneva, Munich, Port-au-Prince, Nice and Florence. Although her past story is difficult, her current story leaks adventure.Not only has Mary been restored and restoried, but she longs to see the same for you. You no longer have to live haunted. I believe your new story starts today. Carl Bard wrote, “Though no one can go back and make a brand-new start, anyone can start from now and make a brand-new ending.”Paul reminds us of this important truth: “This means that anyone who belongs to Christ has become a new person. The old life is gone; a new life has begun!” (2 Corinthians 5:17 NLT). Living in retrospect is a bad idea. It's time to heal, be set free, and find the new story God has for you. Mary has experienced God turning her storm into a story, moving her from a bitter story into a bigger one. Won't you join her on the adventure?

Presented by Julie Busteed I've been looking at what it takes to build healthy relationships. And I've saved the best for last: forgiveness. This verse in Matthew always catches me short. For if you forgive other people when they sin against you, your heavenly Father will also forgive you. But if you do not forgive others their sins, your Father will not forgive your sins (Matthew 6:14-15). I need to take to heart this command! Relationships are living, growing things because they involve people who are growing and changing. And because you are human, there will be times when words are spoken or actions are taken that hurt someone in the relationship. You and I need to forgive others and also ask for forgiveness—things that are not easy to do, except through the power of the Holy Spirit. But wait—there's more! Jesus said we should love our enemies. I look at Jesus' example of laying down his life for you and me. When he was on the cross, suffering, he forgave those who crucified him. Father, forgive them, for they know not what they do (Luke 23:34). That's the ultimate in forgiving your enemies. It really seems quite impossible, doesn't it? Jesus was fully God and fully man. But I don't think that excuses you or me to forgive even our enemies. Corrie Ten Boom and her family helped many Jewish people escape the Nazi's in WW2. As a result, she was arrested and sent to Ravensbrück concentration camp. She survived and wrote books and spoke about her experience. Corrie recounts the following as she was speaking about forgiveness at a church in Munich in 1947: Afterward, I saw him—a man moving toward me through the crowd. I recognized him instantly: a former guard from Ravensbrück, the concentration camp where my sister Betsie and I had been imprisoned for hiding Jews. He approached me, now dressed in civilian clothes, and said, “A fine message, Fräulein. How good it is to know that all our sins are at the bottom of the sea.” Then he extended his hand. “I was a guard at Ravensbrück. I've become a Christian, and I know God has forgiven me, but I would like to hear it from you. Will you forgive me?” I stood frozen, remembering Betsie's suffering and death. Forgive him? I could not. Yet I knew Jesus' words: “If you do not forgive others their sins, your Father will not forgive yours.” Forgiveness is not a feeling—it's an act of the will. So, I prayed silently, “Jesus, help me. I can lift my hand; You supply the feeling.” Mechanically, I reached out—and as I did, a current seemed to pass from my shoulder to our joined hands. A warmth filled my heart. “I forgive you, brother,” I said, “with all my heart.” In that moment, I felt God's love more deeply than ever before.[1] May you and I be obedient and lift our hands and trust God to fill us with his love. --- [1] Corrie Ten Boom, Sherrill, E., & Sherrill, J. L. (2008). The hiding place. Chosen Books.

Episode 499 / Claudia WieserClaudia Wieser is a German artist based in Berlin. Her work has been the subject of solo exhibitions at The Drawing Center, New York; the Contemporary Art Museum, St. Louis, MO; and Smart Museum, Chicago, IL. Her work has been included in recent group exhibitions at the Katonah Museum of Art, Katonah, NY; the Anderson Collection at Stanford University, CA; the Hamburger Bahnhof, Nationalgalerie der Gegenwart, Berlin Germany; Asia Culture Center, Gwangju, South Korea; Contemporary Arts Center New Orleans; Museum für Moderne Kunst, Frankfurt; and Marta Herford Museum for Art, Architecture, Design, Herford, Germany. Wieser's work included in a number or prominent public collections, such as the Contemporary Art Collection of the Federal Republic of Germany; Collection of the Berlin State Museums, Neue Nationalgalerie, Sammlung Goetz, Munich; Deutsche Bundesbank Kunstsammlung, Frankfurt; Mercedes-Benz Art Collection, Germany; K21-International Contemporary Art Collection of the Kunstsammlung North Rhine-Westfalia; the Anderson Collection, Stanford University, CA; the William Louis-Dreyfus Foundation Collection; and the Louiand Zabludowicz Collection, London. She has produced large-scale, site-specific commissions for Dior in Vienna, Paris, and Beverly Hills, the Cleveland Clinic in Ohio, and the City of Munich. In July 2021, Wieser unveiled her first outdoor public installation, commissioned by Public Art Fund, at Brooklyn Bridge Park in New York. In 2023, she presented work in collaboration with historic Yves Saint Laurent couture, designing a set and exhibiting her work at the Museé Yves Saint Laurent, Paris. In 2020 she collaborated with Hérmes to design a catwalk for Paris Fashion Week. She recently completed an outdoor installation at the Stavros Niarchos Foundation Cultural Center in Athens. Claudia earned an MA in Painting and Sculpture from the Academy of Fine Arts, Munich. She lives and works in Berlin. She just opened a solo show at Marianne Boesky gallery. 

Join us live for a special edition of the podcast as we unveil the events for the Deutschland Showdown! We'll break down each event, share insights on the programming, and discuss what to expect from one of Europe's biggest CrossFit throwdowns. Don't miss the inside scoop and live reactions as the competition events are revealed!